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Abstract
Antimicrobial resistance is one of the serious global challenges in the current
century. The fact that resistance genes transfer between bacteria, coupled with the fact
that the world is connected through complex dynamics. Studying microbial behavior
and understanding the different factors coffering microbial resistance to a broad
spectrum of the available drug classes, parallel with a comprehensive analysis of the
natural microbial products as the primary source of the novel antibiotics, might shed
some light on solutions for this problem.
Microbial environments harbor a wide range of secondary metabolites (SM) with
different functional groups. SMs are not directly involved in vital microbial processes
such as reproduction, growth, and development. However, these organic compounds,
which exist in many different chemical structures, carry out a broad range of functions.
Some bioactive SMs are widely used in drug development of various therapeutic classes
such as antibacterial, anticancer, immunosuppressant, diabetic, and cholesterollowering agents. These bioactive compounds’ metabolic pathways are encoded by colocalized genes collectively called Biosynthetic Gene Clusters (BGCs). The majority of
the discovered bioactive natural products are from microbial strains that are
cultivatable. However, the advancement in sequencing techniques, bioinformatics, and
metagenomics opened unlimited opportunities to reach and study the uncultivatable
microbial communities, which represent the more significant fraction of the
underexplored microbial ecology.
In this study, selected samples of seven selected metatranscriptomic/metagenomic
datasets were subjected to assembly, taxonomic assignment to the reads, and assembled
contigs. The aim of this study is two-fold. Firstly, the assembled contigs were then
investigated by two primary distinct computational methods, namely antibiotics and
Secondary Metabolite Analysis Shell (antiSMASH) and deep-learning (deepBGC)
methods. A comparative study was performed to determine the biosynthetic gene
clusters (BGCs) present in each of the included samples and compare their taxonomic
differences. Secondly, the assembled contigs were also analyzed to determine the
antimicrobial resistance (AMR) genes present in each sample by using the Resistance
Gene Identiﬁer (RGI) algorithm, which is a part of the Comprehensive Antibiotic
Resistance Database (CARD). A total of 65 samples from the seven selected
iv

metagenomic and metatranscriptomic datasets were investigated by antiSMASH,
deepBGC pipelines, and CARD in the present study. The different classes of detected
BGCs and their corresponding microbial taxa and the antimicrobial resistance gene
families and their corresponding resistance mechanisms against specific drug classes
were reported.
In the current study, we reported that the datasets with a large extent of variability (i.e.
sex, age and illness state) due to the nature of their environments, such as host
microbiome samples of patients in two ecosystems (COVID-19 & Atopic Dermatitis),
gave the most variable number of BGC classes detected by antiSMASH, where 19
different classes detected in skin microbiome of AD patients and 16 different classes
detected in gut microbiome of COVID-19 patients. On the other hand and due to the
selection pressure on the microbial ecosystems by the wide use of antibiotics, gut
microbiome of COVID-19 patients’ and water sewage samples had more than 70% of
the detected AMR gene families where gut microbiome of COVID-19 patients’ sample
alone reported to had more than 50% of AMR genes detected by CARD.
In conclusion, ecological characteristics and microbial diversity in terms of composition
and relative abundance dramatically affect the dynamics of secondary metabolites’
production and transferring antimicrobial resistance genes between bacteria. Microbial
strains with higher biosynthetic and antimicrobial resistance potentials were enriched
in environments with a rich microbial diversity such as host microbiome (i.e., COVID19 patients), with patterns of abundance of biosynthetic gene clusters and AMR genes
fluctuating by taxonomy.
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Chapter 1: Literature Review & Study Objectives
Introduction
Global health challenges associated with antibiotic and chemotherapeutic
resistances:
On 5 February 2018, the WHO summarized the global challenge associated with
antibiotic resistance as follows, “antibiotic resistance is one of the major threats to
global health, food security, and development, and its effect could extend to include
everyone regardless of their ages or their country (Antibiotic resistance, 2020). A
growing number of infections – such as pneumonia, tuberculosis, gonorrhoea, and
salmonellosis – are becoming harder to treat as the antibiotics used to treat them become
less effective”. Moreover, these infections could lead to longer hospital stays, higher
medical costs, and increased mortality (Antibiotic resistance, 2020). Every year, around
2 million people in the US are infected by a bacterial strain that is resistant to all existing
antibiotics (Martens & Demain, 2017). Furthermore, the resistance of chemotherapeutic
anticancer drugs following therapy is a rising global health challenge (Holohan et al.,
2013). Therefore, there is an unmet need and a great pressure on scientists and the health
communities for discovering new alternative drugs to the current overused ones. Hence,
exploring Natural Products (NPs) could provide a rich source of potentially effective
drugs (Hernando-Amado et al., 2019). Deeper analysis of bacterial behavior in their
respective communities is very crucial, recent studies shed the light on the key role of
environments as a corner stone in not only the transmission of resistance genes between
different bacterial species but also has an important role in emergence of pathogens with
elevated level of resistance (Bengtsson-Palme et al., 2018).
Natural Products and their pharmaceutical importance
In nature, a wide range of secondary metabolites (SM) with different functional
groups is produced by plants and microbes such as bacteria and fungi (Davies & Ryan,
2012). Unlike primary metabolites, SMs are not directly involved in vital processes (i.e.
reproduction, growth & development) of the organism. However, these organic
compounds which exist in many different chemical structures carry out a broad range
of functions. In the mid-20th century, after the great discovery that some microbial
natural products have an antimicrobial activity, an endless intensive research work has
started and a wide range of microbial strains has been randomly screened for the
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presence of natural byproducts with potential therapeutic activities (Davies & Ryan,
2012). These efforts yielded hundreds of thousands of SMs to be extracted and tested
as antimicrobial agents (Davies & Ryan, 2012). Moreover, scientists harnessed the
power of SMs to be utilized as antimicrobials, anticancer, immunosuppressant, and
cholesterol-lowering agents and many others (Ruiz et al., 2010).
These natural products (NP) play a crucial role in drug discovery and
development. According to David J. Newman in 2016, about 70% of anti-infective
medicines originated from natural products (Newman & Cragg, 2016). Over 33 years,
from 1981 to 2014, 32% of small molecule medicines approved by the FDA were
natural products either unmodified (6%) or NP derivatives (26%) (Newman & Cragg,
2020). These drugs include different therapeutic classes such as antimicrobial,
anticancer, diabetic, immunosuppressant, and cholesterol-lowering agents (Newman &
Cragg, 2020).
Natural Products are encoded by Biosynthetic Gene Clusters (BGCs)
Previous reports investigating the characteristics of bioactive secondary
metabolites revealed that the metabolic pathways of SMs are encoded by co-localized
genes collectively called Biosynthetic Gene Clusters (BGCs) (Martin, 1992). Genes
encoding for the biosynthetic pathway enzymes as well as their respective regulatory
genes are contained in the BGC region (Keller et al., 2005). Notably, this fact paves the
way for in silico mining of genomes and metagenomes for secondary metabolites
through BGC neighborhood identification (Medema & Fischbach, 2015). So far,
biosynthetic systems could be grouped into two major classes, Non-ribosomal peptide
synthases (NRPS) and Polyketide synthases (PKS) (Weber & Kim, 2016). On the other
hand, PKS and NRPS are responsible for synthesizing a wide and varied spectrum of
bioactive natural products with much biomedical research and therapeutic applications
such as antimicrobial, antifungal, and immunomodulatory agents, therefore PKS and
NRPS are prevalent targets in genome mining for NPs (Ayuso-Sacido & Genilloud,
2005).
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Tools for BGC mining and NP Discovery
NP mining: past, present and future
Prior to the omics era and the advancement of DNA sequencing technologies,
exploring microorganisms for natural products was mainly conducted in the laboratory
using culture-dependent techniques (Katz & Baltz, 2016). The classical way of natural
products discovery typically consists of four main steps, starting with isolating the
microbial samples, cultures enrichment, extracting candidate products and finally
screening and screening their activities. One major drawback to this traditional method
is the difficulty to culture microorganisms in the lab, besides that not all microbes can
be grown in stable enrichments. To date, only a small fraction of microbial species could
be cultured in the laboratory (Stewart, 2012). Growing microorganisms in the laboratory
under diverse conditions was frequently used to produce and identify secondary
metabolites without being able to specify their biosynthetic pathways at the genetic
levels (Luo et al., 2014). Secondary metabolites functions and activities are usually
characterized and validated through different biochemical assays. Recently, high
throughput biochemical assays enabled the discovery of a wide range of unprecedented
secondary metabolites with potential antimicrobial activities. One notable example, in
a study of sugar fermentation in a Vibrio Cholerae culture, 49 out of 39,000 crude
extracts screened were able to block fermentation pathways and 3 products with novel
antimicrobial activities were identified representing a new class of broad-spectrum
antibiotics (Chen et al., 2019). One major limitation linked to solely using biochemical
assays to detect and characterize SMs is the fact that some SMs are formed at
undetectable levels. Therefore, it will be more feasible to integrate biochemical assays
with other approaches to capture a broader range of SMs produced in nature (Luo et al.,
2014).
Omics Approaches in NP Discovery
Many pharmaceutical drugs which are approved for use by health authorities all
over the world, have been discovered as a result of the traditional approaches of NP
discovery. However, the rate of NP discovery has declined dramatically due to the
difficulties of identifying novel compounds and the recurrent discovery of known
compounds (Li & Vederas, 2009). Extraordinary opportunities for NP discovery
through identification and characterization of biosynthetic gene clusters (BGCs) have
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been created by genome sequencing technology (Jensen, 2016). While the early
approaches in genetics were based on progressing from phenotype to genotype, the
introduction of the next-generation sequencing techniques along with whole-genome
sequencing approaches, creates databases waiting to be mined for novel BGCs
discovery, characterization and synthesis through reverse genetic engineering
approaches, from genotype to phenotype. The massive progress of genomic resources,
especially microbial whole-genome sequencing, not only for the cultured organisms but
also for the uncultured ones, has led to a notable paradigm shift in the uses of
computational approaches in the discovery of bioactive natural products (Hannigan et
al., 2019).
Genome mining is considered a highly time and cost effective approach in NP
discovery because it allows researchers to examine huge genomic datasets whether it
harbor biosynthetic gene clusters of interest or not, before undertaking any expensive
and laborious biochemical steps to produce and extract the NP from microbial host.
Omics approach makes it possible to identify a very large number of BGCs in different
genomes and explore the chosen BGCs for experimental and systematic
characterization (Chen et al., 2019).
In silico Tools for Biosynthetic Gene Clusters Identification
The rapid advances in the DNA sequencing techniques inspired the development
of in silico tools and pipelines to mine microbial genomes and metagenomes for the
presence of biosynthetic gene clusters (Table 1. showing a summary of the tools widely
used to predict the biosynthetic gene clusters). The vast majority of them utilize Basic
Local Alignment Search Tool (BLAST) or proﬁle hidden Markov models (HMMs)
searching tools as a base to identify the genetic signatures accountable for NP
biosynthesis (Ren et al., 2020). These tools include NAPDOS, antiSMASH,
NP.searcher and ClustScan, which are known for their high accuracy yet low levels of
novelty. Moreover, genome mining can be leveraged by the presence of databases for
the known BGCs such as antiSMASH (antibiotics & Secondary Metabolite Analysis
Shell) and MIBiG (Minimum Information about a Biosynthetic Gene Cluster) (Blin et
al., 2017) and (Starcevic et al., 2008). In 2019, Hannigan, Geoffrey D et al. introduced
DeepBGC as a novel approach integrating deep machine learning with natural language
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processing for a better outcome in terms of precision and accuracy in BGCs
identification in microbial genomes (Hannigan et al., 2019).
Table 1. List of the widely used tools and pipelines for prediction of BGCs, data was modified from Ren
H et al., 2020

Tools

Target(s)

Predicted BGC class

Reference

AntiSMASH
NP.searcher
ClustScan
ClusterFinder
NaPDoS
eSNaPD
EvoMining

Bacteria & fungi
Bacteria
Bacteria
Bacteria
Metagenomics
Bacteria
Bacteria

Blin et al., 2013
Li et al., 2009
Starcevic et al., 2008
Cimermancic et al.,2014
Ziemert et al., 2012
Reddy et al., 2014
Selem-Mojica et al., 2019

SMURF

Fungi

PantiSMASH
BAGEL

Plant
Bacteria

Wide range
NRPS, PKS & NRPS/PKS
NRPS & PKS
Wide range
NRPS & PKS
Wide range
Wide range
NRPS, PKS, NRPS/PKS &
DMATS
Wide range
Bacteriocin & RIPP

Khaldi et al., 2010
Kautsar et al., 2017
Van Heel et al., 2013

Genomics and High-throughput Sequencing Technologies
Applying high throughput sequencing techniques in the study of microbial
communities was the biggest reason behind creation of metagenomics research field; as
it enables, for the first time, the study of different genomic sequences of co-existing
microorganisms in a certain community (Ghurye et al., 2016). Sequencing technologies
have been dramatically advanced during the past four decades. Sanger sequencing
considered the first revolution discovery in modern genetic analysis because it allow
complete genome sequencing for the first time. Later, genome sequencing became faster
and much cheaper when the next-generation sequencing (NGS) technologies had
appeared, regardless its advancement, NGS technologies have several drawbacks, most
remarkably the problem of short reads (i.e. it produces up to several hundreds of base
pairs). Recently, such pitfall has been solved by applying the third-generation
sequencing technology which can produce long reads, up to several tens of kb, and
genomic assemblies of extraordinary quality (van Dijk et al., 2018).
Long-read sequencing approaches had been enhanced over the recent years.
Therefore, enabling the study of different genomic sequences and transcriptomes at an
extraordinary resolution, therefore, metagenomics analysis could go deeper to the
species level (Pootakham et al., 2017); (Kuleshov et al., 2016). In the near future, longread sequencing has a great possibility to become a standard method in medical
diagnosis. A recent SMRT study of a patient’s genomic sequence showing undetected
SV despite the aggressive genetic testing by other approaches (Merker et al., 2018).
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Moreover, ambiguous regions in genomes are no longer big issues and can now be
resolved, and more details will be elaborated from transcriptomes. Thus long-read
methods are leading a series of revolutionary new discoveries in genomics research.
Many long-read platforms are now available such as; PacBio, ONT and Illumina/10X
Genomics SLR, table 2 summarize some of their strengths and highlighting their
weaknesses (van Dijk et al., 2018).
Table 2. Strengths and weaknesses of some available long-read platforms, data was modified from van
Dijk EL et al., 2018

Long-read
platform

Strengths

Weaknesses

ONT












PacBio




Ultra long reads; a one Mb reads
can be obtained
Cost effective (e.g. MinION)
Epigenetic modifications are
directly detected
Very fast library preparation
Portable (e.g. SmidgION)
High accuracy with CCS greater
than 99% at 20 passes.
Epigenetic modifications are
directly detected
Overcome repeats problem









Illumina/10X
Genomics SLR






High accuracy and low error rate
Low cost per Gb
No need for special equipment
Library preparation needs small
amount of starting material






High error rate
Library preparation needs big
amount of starting material
Software versions subjected to
numerous changes

Expensive with high cost per Gb
Library preparation needs big
amount of starting material
High error rate
Only Sequel sequencer is
available.
Polymerase reactivity limit read
length
No real long reads
Library preparation needs PCR
amplification
Epigenetic modifications
couldn’t detected directly
Limited capacity (i.e. 384 wells)

The importance of searching for BGCs in metagenomes
Metagenomics is the study of genetic material of samples, recovered directly
from the environment. Unlike the cultivated-based methods such as microbial genome
sequencing, early environmental genomics rely upon sequencing of cloned specific
genes (i.e. 16S rRNA gene) to generate a profile showing the microbial biodiversity in
nature. As a result of applying metagenomics approaches, a whole world of endless
different species has been discovered (Hugenholtz et al., 1998).
The vast majority of the discovered bioactive NP are products of microbial
strains that can be cultivated in the laboratory. However, metagenomics studies open
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unlimited possibilities to reach and study the uncultivated microbial communities which
represent the bigger fraction of the underexplored microbial ecology. Furthermore,
novel biosynthetic pathways are being discovered at higher rates compared to the old
techniques of molecular biology. In addition, metagenomics would also serve as a great
tool to study biocatalysts from the previously overlooked cultivated microbial strains
which reflects a very good probability to discover novel compounds (Wilson & Piel,
2013).
AntiSMASH platform to detect BGCs
AntiSMASH is an inclusive in silico pipeline widely used to explore bacterial
and fungal genome sequences to identify BGCs regions of a broad range of secondary
metabolites (Medema & Fischbach, 2015) such as polyketides, terpenes, non-ribosomal
peptides, bacteriocins, lantibiotics, siderophores, indolocarbazoles, aminocoumarins,
aminoglycosides, beta-lactams, melanins, butyrolactones and others. Although,
antiSMASH relies on signature gene profile HMMs for BGCs identification, they apply
a greedy algorithmic method to extend the explored regions by 5, 10, or 20 kb on both
sides hence closely localized clusters can be merged into what’s called superclusters.
In the latest version (v.5.0) of antiSMASH pipeline (Blin et al., 2019),
superclusters is relabeled as regions, and each region contains several mutually
exclusive candidate BGCs for improved interpretation of hybrid clusters. Moreover,
there are others additional options provided by antiSMASH such as, domain analysis
and annotation of NRPS/PKS, core chemical structure prediction of non-ribosomal
peptides and polyketides, comparative analysis of gene clusters by ClusterBlast, and
protein family analysis of secondary metabolites (smCOG). The output can easily be
visualized through an interactive XHTML page with a user-friendly interface (Ren et
al., 2020). It is worth mentioning that there is another derivative of antiSMASH used
for plant genome mining called plantiSMASH and it has ability to identify biosynthetic
pathways between and within gene clusters by co-expression analysis, and also it can
be used to study the evolutionary conservation of each gene cluster through comparative
genomic analysis (Kautsar et al., 2017).
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Deep learning method to detect BGCs
While they considered the gold standard for genome mining, current available
pipelines, such as ClusterFinder and antiSMASH, are based mainly on signature gene
profile HMMs for BGCs identification but they miss the ability to remember the effects
of position dependencies between distant units or order information (Yoon, 2009);
(Eddy, 2004). This leads to the fact that such tools, HMM-based, could not grasp higher
order information among units (Yoon, 2009; Eddy, 2004), as a result they had a limited
ability to detect BGCs.
To address this algorithmic limitation, Hannigan, Geoffrey D et al. implement a
deep learning approach, DeepBGC, as a novel pipeline integrating deep machine
learning with natural language processing (NLP) for a better outcome in terms of
precision and accuracy in BGCs identification in microbial genomes (Hannigan et al.,
2019). To overcome limitation of HMM-based tools, DeepBGC applying both
Recurrent Neural Networks (RNNs) and vector representations of protein family (Pfam)
domains (Finn et al., 2016) which together have the ability of inherently sensing short
and long term effects of position dependency between neighboring and distant entities
(Sepp Hochreiter et al., 2007).
DeepBGC applies a Bidirectional Long Short-Term Memory (BiLSTM) RNN
besides a word embedding skip-gram neural network, word2veclike, called pfam2vec
(S. Hochreiter & Schmidhuber, 1997). Implementation of DeepBGC produce a higher
performance compared to the leading algorithms in terms of the accuracy of BGC
detection from different genome sequences and the ability of identification of novel
classes of BGCs. Additionally, DeepBGC can classify the identified BGCs based on
their corresponding product classes and the product molecular activity by using a
generic random forest classifiers.
DeepBGC considered a new powerful tool which when applied to bacterial
reference genomes could identify biosynthetic gene clusters coding for bioactive
molecules with putative antimicrobial activity that never identified by the other existing
pipelines. Moreover, the power of this tool might be used in metagenomic analyses in
addition to microbial reference genome, this might leads to a new era of improved BGC
detection and unlimited possibilities to identify novel BGCs (Hannigan et al., 2019).
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Study Objectives
In this study, selected samples pertaining to seven selected metatranscriptomic
/ metagenomic projects were subjected to assembly, taxonomic assignment to the reads
and assembled contigs. Aim of this study is two-fold. Firstly, the assembled contigs
were then investigated by two major distinct computational methods, namely antibiotics
and Secondary Metabolite Analysis Shell (antiSMASH) and deep-learning (deepBGC)
methods. A comparative study was performed to determine the biosynthetic gene
clusters (BGCs) present in each of the included samples, as well as comparing their
taxonomic differences. Secondly, the assembled contigs were also analyzed to
determine the antimicrobial resistance (AMR) genes present in each samples by using
Resistance Gene Identiﬁer (RGI) algorithm which is a part of the Comprehensive
Antibiotic Resistance Database (CARD).
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Chapter 2: Materials & Methods
Samples and Assembly
Whole metagenome samples were obtained from NCBI Sequence Read Archive
(SRA) using prefetch then the downloaded SRA files were converted into paired-ended
FASTQ using fastq-dump. FASTQ files were processed for quality control to remove
adaptor sequences, trim low-quality ends, and remove short reads using fastp (Chen et
al. 2018). Filtered sequences were sub-sampled to one million reads per sample (run)
using Seqtk https://github.com/lh3/seqtk, Figure 1 showing the distribution of filtered
reads of all processed samples per each of the seven selected projects. Sequence reads
were assembled using MEGAHIT (Li et al. 2015), Figure 2 showing the distribution of
the assembled contigs per each project. Assembled contigs were taxonomically
classified using Kraken 2 (Wood et al. 2019). Contigs were filtered for a minimum size
of 1,000 nucleotides.

Figure 1. The distribution of filtered reads of all processed samples per each of the seven selected
projects.
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Figure 2. Distribution of the assembled contigs per each project

Taxonomic analysis, annotation and bioinformatic visualization
Samples were taxonomically classified on the sequence reads using Kraken 2
(Wood et al. 2019) with the default taxonomy database. The abundance of the different
taxonomic levels (species, genus, family, etc.) was estimated using Bracken (Lu et al.
2017).
Using deepBGC tool for BGC mining
Biosynthetic gene clusters were predicted in the assembled contigs using
deepBGC (Hannigan et al. 2019). Contigs classified as human were excluded from
downstream steps (Figure 3).
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Figure 3. The distribution of human abundance per each of the seven selected datasets. Excluded from
downstream analysis

Using antiSMASH tool for BGC mining
The antibiotics and secondary metabolite analysis shell (antiSMASH) platform
was utilized for detection of BGCs. antiSMASH bacterial version 5.0 was used with
default parameters (Medema et al. 2011).
Using CARD’s RGI algorithm for AMR genes detection
The Resistance Gene Identiﬁer (RGI) algorithm present in the Comprehensive
Antibiotic Resistance Database (CARD) was exploited for determination of AMR
genes, drug classes and their resistance mechanisms. The following RGI criterions for
detection were applied, perfect, strict & loose, partial genes included, 95% identity
nudge used and low quality coverage was used in the sequence quality option. (Alcock
BP, Raphenya AR, Lau TTY, et al. 2020). Loose hits were excluded from downstream
steps.
Statistical Analyses
Analytical and visualization analyses were performed using R: A language and
environment for statistical computing. R Foundation for Statistical Computing, Vienna,
Austria. URL https://www.R-project.org/.
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Chapter 3: Results
Assembly pipeline
The study workflow is illustrated in Figure 4, and the details of samples used in
this analysis are available in Table 3. In this study, a total number of 65 samples from
seven selected projects were processed using both antiSMASH and deepBGC pipelines
for BGCs mining and CARD’s RGI algorithm for AMR genes detection. The
total number of reads used was 1,139,543,039 yielded 1,100,630,009 filtered reads
and generating a total of 4,325,515 contigs (Table 4). The contigs (assembled
metagenomes and metatranscriptomes) from the seven selected projects included in the
dataset were investigated by two major distinct computational methods (i.e.
antiSMASH and deepBGC) in addition to CARD’s RGI algorithm for BGCs mining
and AMR genes detection, respectively, the workflow is depicted in Figure 4, and a
comparative study was performed to determine the BGCs present in each of the
included samples along with detection of AMR genes with their corresponding
mechanisms of action and drug classes which they were confer resistance to it. The
assembly metrics are denoted in Table 4.
(1) Download the
dataset (by run)
directly from
NCBI

(2) Quality
control
(3) Taxonomic
classification
of the reads

Screening metagenomic &
metatranscriptomic
datasets for BGCs & AMR
genes

(4) Assembly
(5) Taxonomic
classification
of the contigs

deepBGC
(6) BGCs
prediction
antiSMASH
(7) AMR
genes
detection

CARD

Figure 4. The Study workﬂow for the major steps of the pipeline used to screen the selected metagenomic &
metatranscriptomic projects included in the dataset for BGCs
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Table 3. The selected metagenomic and metatranscriptomic projects included in the dataset. The
accession numbers of the seven selected datasets along with their corresponding abbreviated names and
number of processed samples are denoted. A total number of 65 samples were processed using both
pipelines, antiSMASH and deepBGC for BGCs mining and CAR’s RGI for AMR genes detection.

#
1
2
3
4
5
6
7

Accession number
PRJDB6156
PRJNA340165
PRJNA472006
PRJNA489681
PRJNA624223
PRJNA629394
PRJEB13831

Dataset Name
(Abbreviated)

Number of processed
samples per dataset

Osaka
Tonga
Nose
Skin AD
COVID-19
Mangrove
Sewage
Total number of samples

9
5
12
10
10
10
9
65
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Table 4. Assembly metrics denoted for each sample from the selected metagenomic and metatranscriptomic projects included in the dataset.
Project

Accession

Organism

Organism
Groups

Data type

Location

Reg.
Date

Sequencing of Osaka
Bay see water
metatranscriptome
(at 5 m depth)

PRJDB6156

Marine
metagenome

Metagenomes;
ecological
metagenomes

Transcriptome or
gene expression

Japan: Osaka
Bay

2019-08-01

Investigation of the
metagenome of the
Tonga trench
sediment
(at 9.2 km water depth
and up to 2 m
sediment depth)

PRJNA340165

Marine sediment
metagenome

Metagenomes;
ecological
metagenomes

Metagenome

Pacific Ocean

2016-08-25

Comparative
metagenomic analysis
to assess the
relationship between
human skin
microbiota stability
and patients with
atopic dermatitis
(49 subjects, 33 AD
patients and 16
healthy controls)

PRJNA489681

Multiple

Metagenomes

Metagenome

Singapore

2018-09-06

Metagenomic data
from Mangrove
sediment microbiome
along South China
(samples are from
Aegiceras
corniculatum soil)

PRJNA629394

Sediment
metagenome

Metagenomes;
ecological
metagenomes

Metagenome

South China

2020-04-29
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Sample ID

# of Bases

# of Reads

# of Filtered
Reads

Av.
Contig
Size
(bp)

Largest
Contig
Size
(bp)

7,657
45,800
26,283
36,796
14,877
15,734
8,059
18,774
13,583

487
559
523
454
945
737
1,216
378
846

9,321
59,858
18,690
139,294
327,531
21,593
37,754
8,907
48,051

# of
Contigs

DRR099940
DRR099941
DRR099942
DRR099943
DRR099944
DRR099945
DRR099946
DRR099947
DRR099948
TOTAL (M)
SRR4069403

387.8 M
1.1 G
749.7 M
864.7 M
932.3 M
382.6 M
397.9 M
673.22 M
663.4 M
6151.62
417.20 M

2,667,479
7,509,742
5,334,601
5,921,570
6,505,903
2,612,159
2,769,912
4,642,688
4,650,613

2,649,580
7,382,595
5,239,370
5,813,994
6,377,636
2,581,855
2,719,784
4,581,593
4,593,213

1,846,010

1,804,893

23,966

481

16,294

SRR4069404

1.30 G

5,826,299

5,732,762

110,986

572

47,068

SRR4069405

1.03 G

4,564,804

4,443,188

3,675

519

2,701

SRR4069406

3.09 G

13,747,868

13,377,953

4,220

591

4,378

SRR4069408

1.34 G

5,974,450

5,868,302

927

375

5,306

TOTAL (M)
SRR7802475
SRR7802341
SRR7802306
SRR7802339
SRR7802351
SRR7802349
SRR7802476
SRR7802335
SRR7802352
SRR7802406

7177.20
1.87 G
1.49 G
1.37 G
1.09 G
1.22 G
1.03 G
1.27 G
1.19 G
1.02 G
1.22 G

9,346,770
7,438,112
6,854,660
5,456,812
6,112,223
5,217,253
6,365,734
5,973,209
5,143,013
6,111,603

8,963,662
7,363,758
6,577,935
5,402,061
5,715,559
5,170,642
6,140,000
5,740,124
5,100,160
5,903,453

29,068
43,096
81,181
23,516
29,534
39,712
27,564
56,361
128,979
65,083

1,134
627
687
677
1,386
811
943
673
815
712

327,256
388,652
160,560
312,511
491,444
340,940
104,289
275,594
129,231
145,141

TOTAL (M)
SRR11734720
SRR11734598
SRR11734613
SRR11734656
SRR11734640
SRR11734616
SRR11734716
SRR11734719
SRR11734596
SRR11734597
TOTAL (M)

12770
3.64 G
3.83 G
3.84 G
4.15 G
4.16 G
4.12 G
4.11 G
4.34 G
4.53 G
4.52 G
41240

18,209,386
19,129,190
19,180,698
20,768,796
20,805,669
20,591,363
20,559,523
21,676,963
22,671,952
22,602,093

17,427,535
18,342,777
18,338,146
20,169,382
20,243,850
19,765,013
19,722,052
20,830,425
21,791,702
21,705,388

9,660
10,852
25,121
52,455
48,897
29,634
13,382
15,150
17,194
16,722

422
424
461
465
516
459
423
426
426
424

5,337
7,412
43,105
32,405
46,618
45,747
10,080
7,083
6,779
6,841

PRJNA624223

Feces
metagenome

Human skin
metagenome and 16S
(Epithelium of
external nose)

PRJNA472006

Human skin
metagenome

Global surveillance of
infectious diseases and
antimicrobial
resistance from
sewage

PRJEB13831

Sewage

Gut microbiome
alterations and
longitudinal kinetics
in 15 COVID-19
patients.

Metagenomes;
organismal
metagenomes

Raw sequence reads

Hong Kong

2020-04-10

Metagenomes;
organismal
metagenomes

Raw sequence reads

Denmark:
Copenhagen

2018-05-18

Metagenomes

Raw sequence reads

Global project

2019-02-01

Tao Zuo et al., 2020

TOTAL

SRR12328926
SRR12328948
SRR12328907
SRR12328910
SRR12328904
SRR12328942
SRR12328943
SRR12328897
SRR12328903
SRR12328951
TOTAL (M)
SRR9696273
SRR9696274
SRR9696275
SRR9696276
SRR9696277
SRR9696278
SRR9696279
SRR9696280
SRR9696281
SRR9696282
SRR9696283
SRR9696284
TOTAL (M)
ERR1713410

2.85 G
3.10 G
3.05 G
3.16 G
3.32 G
3.20 G
3.41 G
3.52 G
3.68 G
3.76 G
33050
8.2G
13.9G
9.1G
9.1G
8.8G
13.2G
9.6G
8.9G
12G
11.2G
7.8G
11.9G
123700
8.2G

10,119,197
10,831,211
10,776,976
11,141,802
11,404,379
11,471,303
12,238,736
12,313,208
13,018,722
13,019,613

9,893,607
10,698,264
10,650,748
10,735,634
11,294,382
11,240,588
12,012,970
12,205,473
12,883,352
12,900,042

15,215
7,994
156,679
409,228
136,136
31,516
14,049
149,575
116,637
25,191

1,195
3,351
1,299
490
1,363
1,614
1,123
1,253
1,560
2,502

732,744
403,502
524,513
385,138
472,741
585,648
349,596
481,689
493,077
411,905

32,489,498
55,186,070
36,087,682
35,935,443
34,846,139
52,223,806
37,987,223
35,189,492
47,577,639
44,434,656
30,778,753
47,163,030

31,778,213
53,638,515
35,391,282
35,178,043
34,191,678
50,934,770
37,080,691
34,402,185
46,427,813
43,402,757
30,118,478
46,080,142

94,964
43,565
18,676
30,113
10,537
44,869
44,017
3,275
45,784
42,952
7,434
23,316

358
337
335
335
376
337
332
329
339
338
513
331

37,829
16,576
5,245
16,689
16,683
4,667
16,668
3,917
16,690
16,668
147,689
16,668

27,296,861

25,450,270

253,567

396

23,682

ERR1713411

5.8G

19,360,109

18,017,557

233,836

394

32,340

ERR1726031

1.2G

3,919,046

3,659,867

59,188

382

6,765

ERR1726032

4.6G

15,288,191

14,959,449

222,760

396

31,300

ERR1726033

11.5G

38,069,060

36,914,867

236,108

397

27,547

ERR1726034

1.9G

6,416,235

6,078,322

107,287

386

15,425

ERR1726035

4.8G

15,847,330

14,650,560

195,063

392

14,190

ERR2592282

5.8G

19,303,711

18,088,371

232,720

393

38,612

ERR2592343

13G

43,018,798

36,090,777

218,766

391

12,778

TOTAL (M)

56800
1,139,543,039

1,100,630,009

4,325,515

65 Samples
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280888.82

-

-

Taxonomical Assignment
To understand the dynamics of SM production in the different environments,
this require to get the taxonomical assignment for the sequence reads of each sample.
Samples were taxonomically classified on the sequence reads using Kraken 2 with the
default taxonomy database. The abundance of the different taxonomic levels (species,
genus, family, etc.) was estimated using Bracken. This exercise resulted into
understanding the community structure and the abundance of each microbial group
within each sample under test. Figure 5 showed how the relative abundance at genus
level differ between samples of each projects, and it was clear that samples of some
projects were dominated by few signature genera such as the sample of Osaka which
were dominated mainly by Pseudomonas and Synechococcus. On the other hand,
metagenomic skin samples of AD patients were dominated mainly by Cutibacterium,
while Corynebacterium appeared like it stands alone in the samples of the Human skin
metagenome from epithelium of external nose project (Nose).

Figure 5. Barplot showing the relative abundance of all the detected microbial taxa, at the genus level,
of the processed samples per each of the seven selected datasets.
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To show how the different samples will be clustered based on the relative abundance of
taxa we constructed both a PCA and t-SNE graphs (Figures 6 & 7). Projects like Osaka
bay and water sewage appeared completely separated from the other five projects, while
the rest shows some connections which mainly due to the presence of common genera,
such as Corynebacterium and Cutibacterium which explained the presence of some
samples from the Human skin metagenome from epithelium of external nose and Tonga
trench project around the samples of the skin project of AD patients. These findings
might be of great impact on understanding the dynamics of SM production in different
environments.

Figure 6. PCA analysis for the ecosystems, based on the assigned microbiome taxa. (A) Plot showing
the most significant Principal Components, PC1, PC2 & PC3, all together represent 82% variations. (B)
PCA biplot of the different samples from each of the seven selected datasets. PC1 & PC2 representing
the most significant principle components and they cumulatively represent 68.7% and different samples
were clustered separately based on their relative abundance of the taxa. Different datasets were color
coded.
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Figure 7. t-SNE analysis for the datasets, based on the assigned microbiome taxa.

BGC profile of samples in the dataset as detected by antiSMASH
By using antiSMASH a total 776 BGCs regions were detected from the selected
projects, 45 samples from 65 processed samples gave hits with antiSMASH (Figure 8).
26 different BGC classes were detected (Figure 9), the seven major detected classes
which collectively represent about 80% of the total detected BGCs classes were NRPS
(23%), bacteriocin (15%), NRPS-like (10%), terpene (10%), sactipeptide (9%),
arylpolyene (7%) and siderophore (5%). About 35% of the detected BGCs came from
5 different bacterial genera, Pseudomonas contributed the most with 12% and it was
obvious that the most dominant species was Pseudomonas sp. J380 which contributed
alone by 10% of the total percentage of the detected BGCs. The genus Gordonia came
in the second place with 8%, while the genus Corynebacterium produced 7% of the
detected BGCs and both Cutibacterium and Blautia genera contributed by the same
percentage of the detected BGCs, about 4% for each genus. To figure out the major
differences between the processed samples from each environments in terms of BGCs
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contents and their corresponding microbial contributors, we deeply analyzed the
processed samples from each dataset and the results were explained in details hereunder.

Figure 8. Distribution of the detected BGCs by antiSMASH in all datasets (A) Distribution of
the absolute number of the detected BGCs by antiSMASH (B) Distribution of the normalized
percentages of the detected BGCs by antiSMASH. Percentages were normalized to the number
of assembled bases per dataset.

Figure 9. Distribution of the absolute number of the detected BGCs classes by antiSMASH in
all datasets.
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About 36.48%* (i.e. 101 BGCs) of the detected BGCs of 9 different classes
were from the metatranscriptomic marine samples from Osaka Bay see water project.
Only 6 samples out of 9 processed samples gave hits with antiSMASH pipeline. NRPS
and bacteriocin represent the vast majority of the detected classes by 64%, NRPS class
came in the first place by 44% while the percentage of the detected bacteriocin class
was 20% and the percentages of the rest seven detected classes were as follows, 9%
terpene, 7% NRPS-like, 7% arylpolyene, 5% hserlactone, 5% siderophore, 3%
betalactone and only 1 BGC was NAGGN. 95% of the detected BGCs was produced
by two genera, Pseudomonas and Synechococcus. Pseudomonas contributed the most
with 82% and it was obvious that the most dominant species was Pseudomonas sp. J380
which contributed alone by 74% from the total percentage of the detected BGCs.
Synechococcus came in the second place and contributed by 13% of the total detected
classes. * Percentage was normalized to the total number of bases.

The results of metagenomic samples from the gut microbiome project of
COVID-19 patients were analyzed. In this study, 10 samples were processed, all
samples gave hits and antiSMASH detected 16 different BGCs classes with a total
number of 243 BGCs. Only 5 classes out of 16 different classes, represent about 80%
of the total detected classes as follows; 28% was sactipeptide, NRPS represent 19%,
bacteriocin was 16%, arylpolyene and lanthipeptide represent 12% and 7% respectively.
The rest of detected classes (11 classes) which collectively represent about 19% were,
NRPS-like, terpene, T3PKS, lassopeptide, betalactone, resorcinol, siderophore,
thiopeptide, nucleoside, butyrolactones and ladderane. About 43% of the detected
BGCs were from 5 genera, 13% of BGCs was produced by Blautia, and 12% was from
Lachnospiraceae, 7% was Bacteroides, 6% was Faecalibacterium and Streptococcus
contributed with 5% of the detected BGCs.

Ten skin microbiome metagenomic samples were randomly chosen from a
comparative metagenomic analysis study conducted in Singapore to assess the
relationship between human skin microbiota stability and patients with atopic
dermatitis. All samples gave hits with antiSMASH and it detected 19 different BGCs
classes with a total number of 272 BGCs. Out of the 19 detected classes, 6 represent
about 81% of the total number of the detected BGCs. These classes were NRPS, NRPSlike, siderophore, terpene, bacteriocin and T1PKS which represent 27%, 17%, 10%,
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10%, 9% and 8% respectively. The rest of detected classes (13 classes) which
collectively represent about 19% were, ectoine, T3PKS, hserlactone, thiopeptide,
betalactone,

lanthipeptide,

arylpolyene,

CDPS,

LAP,

hglE-KS,

ladderane,

butyrolactones and lassopeptide. More than half of the detected BGCs (i.e. about 57%)
were produced by 4 genera; Gordonia, Corynebacterium, Cutibacterium and
Staphylococcus which represent 24%, 15%, 12% and 6% of the total detected BGCs
respectively.

Five marine sediment metagenomic samples from Tonga trench sediment in the
Pacific Ocean were processed by antiSMASH to screen for BGCs contents. Only 2
samples gave hits and antiSMASH detected a total of 23 BGCs with 9 different classes.
The detected classes with their corresponding percentages were as follows, (17%)
arylpolyene, (17%) NRPS-like, (17%) hglE-KS, (13%) bacteriocin, (9%) phosphonate,
(9%) terpene, (9%) hserlactone, (4%) T1PKS and (4%) NRPS. There was no much data
about the microbial composition of the processed samples because antiSMASH could
not assign about 43% of the detected BGCs to any microbial species.

Another ten metagenomic samples from Mangrove sediment microbiome along
South China were processed and 5 of them gave hits with antiSMASH. A total of 12
BGCs with 6 different classes were detected. The detected classes with their
corresponding percentages were as follows, (33%) bacteriocin, (17%) arylpolyene,
(17%) NRPS-like, (17%) terpene, (8%) lassopeptide and (8%) NRPS. There was no
much data about the microbial composition of the processed samples because
antiSMASH could not assign about 58% of the detected BGCs to any microbial species.

Twelve samples were a Human skin metagenome from epithelium of external
nose from a study conducted in Copenhagen; Denmark. Only 3 samples gave hits with
antiSMASH and it was obvious that only one dominant genus, Corynebacterium
produced 5 different classes of BGCs and a total 23 BGCs were detected as follows; 9
NRPS representing 39%, 5 terpene (22%), 5 siderophore (22%), 2 NRPS-like (9%) and
2 T1PKS (9%). There was no much data about the microbial composition of the
processed samples because antiSMASH could not assign about 53% of the detected
BGCs to any microbial species.
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The last 9 samples were from the Global Sewage Project. A total of 102 BGCs
with 12 different classes were detected. The detected BGCs classes with their
corresponding percentages were as follows, (30%) bacteriocin, (28%) terpene, (10%)
hserlactone, (8%) NRPS-like, (7%) arylpolyene, (5%) sactipeptide, (3%) resorcinol,
(3%) T3PKS, (2%) ectoine, (2%) butyrolactones, (1%) phenazine and (1%) RaS-RiPP.
Almost 50% of the produced BGCs was from 3 major genera; Streptococcus comes in
the first place with 27%, Neisseria produced about 15% and 6% was from Polaromonas.
What is interesting about this project is that there are few unique BGCs classes detected
by antiSMASH which are not appear in the previous 6 projects, such as resorcinol,
ectoine, phenazine and RaS-RiPP. Moreover, these classes are not produced by the
dominant genera (i.e. resorcinol is produced either by Brevundimonas or
Pasteurellaceae, ectoine produced by Arcobacter and phenazine was produced by
Escherichia coli) each genera represent only about 1% of the total microbial
community. We discussed this point with some details elsewhere in this study.
BGC profile of samples in the dataset as detected by DeepBGC
Before we decide to use deepBGC pipeline, we did a pilot trial to test deepBGC
output and the results were very interesting and rich with huge amount of data compared
to antiSMASH. Although it is not an objective of this study to perform a comparative
analysis between the results obtained by both pipelines, however, we decide to use
deepBGC to get a deeper insight and grasp more information about the processed
samples and their corresponding communities.
For a better understanding of deepBGC results here are some important points
about this algorithm. The current deepBGC pipeline could detects only six different
BGCs classes, five specific (i.e. Polyketide, NRP, RiPP, Saccharide and Terpene) and
one unspecific annotated by the algorithm as “other”. In addition to the huge amount of
data generated by deepBGC there is another major advantage of it because it could
assign four different products’ activities (i.e. antibacterial, antifungal, inhibitor and
cytotoxic) to each detected BGCs with a very high coverage percentage, almost 96% of
processed samples. We tried to figure out the annotation mechanism of deepBGC, we
discovered that there is a scoring system for both class and product activity annotations,
the pipeline assigned class and activity for hits with scores ≥ 0.5 and if there are more
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than one class or activity with a score ≥ 0.5, all will be annotated to the same hit,
separated by a hyphen sign (-).

Unlike antiSMASH, deepBGC detected large number of BGCs classes and a
total 79,771 BGCs were detected from the selected datasets (Figure 10), moreover all
the 65 samples gave hits. DeepBGC assigned BGCs classes to around 20% of hits
(15,714 hits) as follows; 39% of hits was Polyketide, 18% RiPP, 18% Saccharide, 10%
others, 7% NRP, 4% Terpene, 2% Polyketide-Terpene, 1% NRP-Polyketide and 1%
Saccharide-Terpene (Figure 11).

Figure 10. Distribution of the detected BGCs by deepBGC in all datasets (A) Distribution of
the absolute number of the detected BGCs by deepBGC (B) Distribution of the normalized
percentages of the detected BGCs by deepBGC. Percentages were normalized to the number
of assembled bases per dataset.
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Figure 11. Distribution of the absolute number of the detected BGCs classes by deepBGC in
all datasets.

A major advantage of deepBGC is that it could assign product activity to each single
detected BGC class with a very high coverage rate. In this study deepBGC assigned
product activity to 96% of the hits and the results were 97% of hits have an antibacterial
activity, 1% inhibitor, 1% antibacterial-antifungal and less than 1% cytotoxic (Figure
12). About 31% of the detected BGCs were products of microbial species belong to one
of the following eight genera, 7% from Bacteroides, 5% Pseudomonas, 5%
Corynebacterium, 4% Gordonia, 3% Blautia, 3% Escherichia, 2% Faecalibacterium
and 2% Cutibacterium.
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Figure 12. Distribution the assigned product activities by deepBGC in all datasets. (A)
Distribution of the absolute number of the assigned products’ activities by deepBGC (B)
Distribution of the normalized percentages of the assigned products’ activities by deepBGC.
Percentages were normalized to the number of assembled bases per dataset.

DeepBGC detected 4,795 BGCs from the nine metatranscriptomic marine samples from
Osaka Bay see water project. All processed samples gave hits with deepBGC pipeline.
DeepBGC assigned BGCs classes to around 17% of the hits (832 hits) as follows; 49%
of hits was Polyketide, 13% NRP, 12% RiPP, 8% other, 7% Saccharide, 6% Terpene,
3% Saccharide-Terpene, 2% Polyketide-Terpene and 1% NRP-Polyketide. In this
project deepBGC assigned product activity to almost 96% of the hits and the results
were 97% of hits have an antibacterial activity, 2% inhibitor and 1% antibacterialantifungal. DeepBGC specified the microbial species to about 82% of the hits and more
than 80% of the detected BGCs were products of microbial species belong to one of the
following 3 genera, 63% from Pseudomonas, 15% Synechococcus, and 4% Candidatus.

The results of metagenomic samples from the gut microbiome project of
COVID-19 patients were analyzed. In this study, 10 samples were processed, all
samples gave hits and deepBGC annotated BGCs classes to around 20% of the hits
(6,852 hits) as follows; 30% of hits was Polyketide, 26% Saccharide, 23% RiPP, 11%
other, 4% NRP, 3% Terpene, 1% Polyketide-Terpene and 1% NRP-Polyketide. In this
project deepBGC assigned product activity to almost 96% of the hits and the results
were 98% of hits have an antibacterial activity, 1% inhibitor, 1% antibacterialantifungal and 1% cytotoxic. DeepBGC specified the microbial species to about 79%
of the hits and about 33% of the detected BGCs were products of microbial species
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belong to one of the following 4 genera, 16% from Bacteroides, 7% Blautia, more than
5% Lachnospiraceae and 5% Faecalibacterium.
A total of 18,683 hits were detected by deepBGC from 10 skin microbiome
metagenomic samples of patients with atopic dermatitis. DeepBGC annotated BGCs
classes to around 22% of the hits (4,137 hits) as follows; 46% of hits was Polyketide,
14% RiPP, 10% Saccharide, 10% NRP, 8% Other, 5% Terpene, 5% PolyketideTerpene, 2% Saccharide-Terpene and 1% NRP-Polyketide. Moreover, deepBGC
assigned product activity to almost 95% of the hits and 96% of hits have an antibacterial
activity, 2% inhibitor and 2% antibacterial-antifungal. DeepBGC specified the
microbial species to about 75% of the hits and more than 50% of the detected BGCs
were products of microbial species belong to one of the following 5 genera, 16% from
Gordonia, 14% Corynebacterium, 7% Mycolicibacterium, 7% Cutibacterium and 7%
Micrococcus.
The five samples from Tonga trench project gave 2,751 hits with deepBGC. The
pipeline annotated about 21% of these hits (567 hits) with different BGCs classes as
follow; 52% of hits belonged to Polyketide, 12% RiPP, 11% Terpene, 8% Others, 7%
NRP, 5% Saccharide, 4% Polyketide-Terpene, 1% Saccharide-Terpene and 1% NRPPolyketide. On the other hand, 96% of hits annotated by deepBGC with three different
activities, the majority about 96% have an antibacterial activity, 3% antibacterialantifungal and about 1% inhibitor. The pipeline also specified the microbial species to
about 45% of the hits and about 20% of the detected BGCs were products of microbial
species belong to one of the following 2 genera, 16% Cutibacterium and 4% belonged
to Pseudomonas.

The then metagenomic samples from Mangrove sediment microbiome project
gave 1,624 hits with deepBGC. The pipeline annotated about 14% of these hits (230
hits) with different BGCs classes as follow; 46% of hits belonged to Polyketide, 13%
Saccharide, 11% NRP, 9% RiPP, 8% Others, 6% Terpene, 5% Polyketide-Terpene and
1% Saccharide-Terpene. On the other hand, 97% of the total detected hits annotated by
deepBGC with one of two different activities, the vast majority about 99% have an
antibacterial activity and 1% inhibitor. The pipeline also specified the microbial species
to about 52% of the hits and about 24% of the detected BGCs were products of microbial
species belong to one of the following 3 genera, 10% Altererythrobacter, 8%
Erythrobacter and 6% belonged to Candidatus Plagibacter.
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The twelve metagenomic samples from a study conducted in Copenhagen;
Denmark gave about 1,351 hits with deepBGC. The pipeline annotated about 21% of
these hits (283 hits) with different BGCs classes as follow; 45% of hits belonged to
Polyketide, 17% RiPP, 12% Other, 9% NRP, 8% Saccharide, 7% Terpene, 1%
Polyketide-Terpene and 1% NRP-Polyketide. Moreover, about 95% of the total
detected hits annotated by deepBGC with one of three different activities, the vast
majority, about 96%, have an antibacterial activity, 2% inhibitor and 1% antibacterialantifungal. The pipeline also specified the microbial species to about 81% of the hits
and the genus Corynebacterium was the most dominant as it represents about 78% of
the whole microbial community from the processed samples.
The last 9 samples were from the Global Water Sewage Project. DeepBGC
pipeline gave 16,682 hits, 17% of it (i.e. 2,813 hits) annotated by deepBGC with
different BGCs classes. The majority 44% were Polyketide, 17% RiPP, 15%
Saccharide, 12% Other, 5% NRP, 4% Terpene, 2% Polyketide-Terpene, 1% NRPPolyketide. The pipeline assigned product activity to almost 97% of the total hits and
the vast majority, 97%, was antibacterial, 1% was inhibitor and 1% was antibacterialantifungal. DeepBGC specified the microbial species to about 77% of the hits and about
31% of the detected BGCs were products of microbial species belong to one of the
following 6 genera, 9% Escherichia, 6% Acidovorax, 5% Neisseria, 4% Streptococcus,
3% Arcobacter and the last 3% belonged to Pseudomonas.

AMR genes profile of samples in the dataset as detected by CARD’s RGI
The second major goal of this study was to detect the antimicrobial resistance
genes of the samples from the selected metagenomes, along with their mechanisms of
actions and the drug classes which it confers resistance to. Here we used Resistance
Gene Identiﬁer (RGI) algorithm from The Comprehensive Antibiotic Resistance
Database (CARD) with the following criterions for detection (perfect, strict & loose,
partial genes included, 95% identity nudge used) of AMR genes. Loose hits were
excluded, here only results of perfect and strict hits were reported to ensure that they
are either perfect matches or passed the curated bit-score. In our study, the selected sixty
five samples from the different seven selected projects were analyzed by CARD’s RGI
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and a total number of around 1216 AMR gene families were detected which confer
resistance to about 2602 drug classes by 1163 resistance mechanisms. Figures 18 – 20
show the distribution of the detected AMR gene families, drug classes and resistance
mechanisms of all samples from the seven selected metagenomes, respectively. Gut
microbiome of COVID-19 patients’ samples and water sewage samples represent more
than 70% of antibiotic resistance abundance, while samples of the rest five selected
metagenomes represent less than 30%. To eliminate the effect of the number of bases
all percentages were normalized by dividing the total detected number of AMR gene
families, drug classes and resistance mechanisms by the total number of used bases per
each of the seven selected metagenomes.

Figure 13. Distribution the detected AMR genes families by CARD in all datasets. (A)
Distribution of the absolute number of detected AMR genes families by CARD. (B) Distribution
of the normalized percentages of the detected AMR genes families. Percentages were
normalized to the number of assembled bases per dataset.
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Figure 14. Distribution the detected drug classes by CARD in all datasets. (A) Distribution of
the absolute number of detected drug classes by CARD. (B) Distribution of the normalized
percentages of the detected drug classes. Percentages were normalized to the number of
assembled bases per dataset.

Figure 15. Distribution the detected resistance mechanisms by CARD in all datasets. (A)
Distribution of the absolute number of detected resistance mechanisms by CARD. (B)
Distribution of the normalized percentages of the detected resistance mechanisms. Percentages
were normalized to the number of assembled bases per dataset.

The results of metagenomic samples from the gut microbiome project of COVID-19
patients were analyzed. In this study, 10 samples were processed, 9 samples gave
perfect hits (76 hits) while all samples gave strict hits (468 hits). CARD’s RGI algorithm
detected a total of 608 AMR genes from different 55 families which represent 48.26%
of all detected AMR gene families of all processed samples from the seven selected
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metagenomes. Such AMR genes confer resistance to a total of 1378 drugs from different
37 classes which represent 51.51% of the overall results (Table 5).
Table 5. Drug classes detected by CARD's RGI in gut microbiome of COVID-19 patients’ samples. A
total 1378 drug classes from 32 different classes, according to CARD’s classification were detected.
#
Drug Classes
Detected #
%
tetracycline antibiotic
203
14.73%
1
fluoroquinolone antibiotic
174
12.63%
2
Penam
118
8.56%
3
Cephalosporin
105
7.62%
4
macrolide antibiotic
95
6.89%
5
aminoglycoside antibiotic
73
5.30%
6
rifamycin antibiotic
69
5.01%
7
phenicol antibiotic
59
4.28%
8
glycylcycline
49
3.56%
9
44
3.19%
10 lincosamide antibiotic
43
3.12%
11 Cephamycin
42
3.05%
12 peptide antibiotic
42
3.05%
13 Triclosan
34
2.47%
14 aminocoumarin antibiotic
32
2.32%
15 streptogramin antibiotic
23
1.67%
16 Carbapenem
23
1.67%
17 Penem
20
1.45%
18 diaminopyrimidine antibiotic
20
1.45%
19 nucleoside antibiotic
19
1.38%
20 acridine dye
17
1.23%
21 Monobactam
16
1.16%
22 Fosfomycin
16
1.16%
23 glycopeptide antibiotic
7
0.51%
24 nitrofuran antibiotic
6
0.44%
25 nitroimidazole antibiotic
6
0.44%
26 oxazolidinone antibiotic
6
0.44%
27 pleuromutilin antibiotic
5
0.36%
28 benzalkonium chloride
5
0.36%
29 Rhodamine
4
0.29%
30 elfamycin antibiotic
2
0.15%
31 aminocoumarin antibiotic
1
0.07%
32 sulfonamide antibiotic
GRAND TOTAL 1378
100.00%

These genes confer resistance to the different drug classes by 6 different
resistance mechanisms of a total 580 mechanisms, which represent 48.68% of the
overall detected resistance mechanisms. The top three detected AMR gene families
were, resistance-nodulation-cell division (RND) antibiotic efflux pump (28.62%),
major facilitator superfamily (FS) antibiotic efflux pump (17.11%) and tetracyclineresistant ribosomal protection protein (10.36%), which represent 56.09% of the 608
detected AMR gene families. Whereas, the top first five drug classes which represent
50.44% of the detected 1378 drug classes were as follows, tetracycline antibiotic
(14.73%), fluoroquinolone antibiotic (12.63%), penam (8.56%), cephalosporin (7.62%)
and macrolide antibiotic (6.89%). On the other hand, the six detected resistance
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mechanisms by which genes introduce drug resistance, were as follows; antibiotic
efflux (47.93%), antibiotic target alteration (20%), antibiotic inactivation (13.28%),
antibiotic target protection (12.24%), antibiotic target replacement (3.97%) and reduced
permeability to antibiotic (2.59%).

The nine metagenomic samples from the Global Water Sewage Project come in
the second place after gut microbiome of COVID-19 patients’ samples in terms of
antibiotic resistance abundance. All samples gave hits with RGI where; 96 of hits were
perfect matches and 370 of the hits were strict. A total 506 AMR genes belong to 37
different families was detected, which represent 23.37% of all detected AMR gene
families. These genes confer resistance to 1031 drugs belong to 29 different classes
which collectively represent 22.42% of the whole detected drug classes (Table 6).
Table 6. Drug classes detected by CARD's RGI in water sewage samples. A total 1031 drug classes
from 29 different classes, according to CARD’s classification were detected.
#
Drug Classes
Detected #
%
tetracycline antibiotic
155
15.03%
1
Penam
123
11.93%
2
fluoroquinolone antibiotic
103
9.99%
3
macrolide antibiotic
90
8.73%
4
Cephalosporin
87
8.44%
5
aminoglycoside antibiotic
77
7.47%
6
phenicol antibiotic
49
4.75%
7
Cephamycin
37
3.59%
8
rifamycin antibiotic
35
3.39%
9
30
2.91%
10 Glycylcycline
29
2.81%
11 Triclosan
25
2.42%
12 aminocoumarin antibiotic
22
2.13%
13 peptide antibiotic
20
1.94%
14 sulfonamide antibiotic
18
1.75%
15 acridine dye
17
1.65%
16 nucleoside antibiotic
15
1.45%
17 diaminopyrimidine antibiotic
15
1.45%
18 lincosamide antibiotic
15
1.45%
19 streptogramin antibiotic
14
1.36%
20 Monobactam
14
1.36%
21 Penem
9
0.87%
22 oxazolidinone antibiotic
9
0.87%
23 pleuromutilin antibiotic
7
0.68%
24 Carbapenem
5
0.48%
25 nitroimidazole antibiotic
4
0.39%
26 Fosfomycin
3
0.29%
27 Carbapenem
2
0.19%
28 benzalkonium chloride
2
0.19%
29 Rhodamine
GRAND TOTAL 1031
100.00%
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These genes confer resistance to the different drug classes by 6 different
resistance mechanisms of a total 487 mechanisms, which represent 23.78% of the
overall detected resistance mechanisms. Three major AMR gene families which
represent 55.73% of 506 detected AMR genes were as follows; major facilitator
superfamily (MFS) antibiotic efflux pump (24.90%), resistance-nodulation-cell
division (RND) antibiotic efflux pump (20.75%) and tetracycline-resistant ribosomal
protection protein (10.08%). Out of the 29 different drug classes, there were 6 major
classes which represent 61.59% from the total number of 1031 detected drugs, and they
were as follows; tetracycline antibiotic (15.03%), penam (11.93%), fluoroquinolone
antibiotic (9.99%), macrolide antibiotic (8.73%), cephalosporin (8.44%) and
aminoglycoside antibiotic (7.47%). As in gut microbiome of COVID-19 patients’
samples, there were six different resistance mechanisms detected but with different
percentages as follows; antibiotic efflux (45.38%), antibiotic inactivation (27.72%),
antibiotic target protection (13.14%), antibiotic target replacement (6.78%), antibiotic
target alteration (6.37%) and reduced permeability to antibiotic (0.62%).

The results of the rest five selected metagenomes represent less than 30%
(normalized value) in terms of AMR gene family, drug classes and resistance
mechanisms. No perfect hits were detected from the nine metatranscriptomic marine
samples from Osaka Bay see water project while there were 26 strict hits from 5 samples
detected. A total of 36 AMR genes from different 5 families which represent 15.35%
of all detected AMR gene families of all processed samples from the seven selected
metagenomes. The detected AMR genes confer resistance to a total of 77 drugs from
different 11 classes which represent 15.46% of the overall results (Table 7).
Table 7. Drug classes detected by CARD's RGI in Osaka bay samples. A total 77 drug classes from 11
different classes, according to CARD’s classification were detected.
#
Drug Classes
Detected #
%
aminoglycoside antibiotic
10
12.99%
1
fluoroquinolone antibiotic
15
19.48%
2
tetracycline antibiotic
15
19.48%
3
triclosan
6
7.79%
4
cephalosporin
5
6.49%
5
glycylcycline
5
6.49%
6
penam
5
6.49%
7
acridine dye
5
6.49%
8
rifamycin antibiotic
5
6.49%
9
5
6.49%
10 phenicol antibiotic
1
1.30%
11 macrolide antibiotic
GRAND TOTAL 77
100.00%
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The detected AMR genes confer resistance to the different drug classes by 3
different resistance mechanisms of a total 31 mechanisms, which represent 13.98% of
the overall detected resistance mechanisms. The five detected AMR gene families were,
resistance-nodulation-cell division (RND) antibiotic efflux pump (41.67%), major
facilitator superfamily (MFS) antibiotic efflux pump (16.67%), APH(3'') (13.89%),
APH(6) (13.89%) and ATP-binding cassette (ABC) antibiotic efflux pump (13.89%),
which all represents 14.52% of the 36 detected AMR gene families. However, the first
major three drug classes which represent 51.95% of the 77 detected drug classes were
as follows, tetracycline antibiotic (19.48%), fluoroquinolone antibiotic (19.48%) and
aminoglycoside antibiotic (12.99%). The three detected resistance mechanisms by
which genes introduce drug resistance, were as follows; antibiotic efflux (51.61%),
antibiotic inactivation (32.26%) and antibiotic target alteration (16.13%).
On the other hand, from the ten samples of Skin AD metagenomes, only 4
samples gave 7 perfect hits whereas all samples gave strict hits and the total detected
number was 53 hits. The processed samples yielded a total number of 61 AMR genes
from different 25 families which represent 12.53% of all detected AMR gene families
compared to the rest of samples from the seven selected projects. These AMR genes
confer resistance to a total of 101 drugs from different 23 classes which represent 9.77%
of the overall results (Table 8).
Table 8. Drug classes detected by CARD's RGI in skin AD patients’ samples. A total 101 drug classes
from 23 different classes, according to CARD’s classification were detected.
#
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23

Drug Classes
aminoglycoside antibiotic
macrolide antibiotic
lincosamide antibiotic
streptogramin antibiotic
fluoroquinolone antibiotic
phenicol antibiotic
Penam
tetracycline antibiotic
peptide antibiotic
oxazolidinone antibiotic
pleuromutilin antibiotic
fusidic acid
lincosamide antibiotic
diaminopyrimidine antibiotic
acridine dye
aminocoumarin antibiotic
elfamycin antibiotic
Cephalosporin
Fosfomycin
glycopeptide antibiotic
Mupirocin
rifamycin antibiotic
sulfonamide antibiotic
GRAND TOTAL
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Detected #
15
11
11
11
9
7
6
5
4
3
3
2
2
2
2
1
1
1
1
1
1
1
1
101

%
14.85%
10.89%
10.89%
10.89%
8.91%
6.93%
5.94%
4.95%
3.96%
2.97%
2.97%
1.98%
1.98%
1.98%
1.98%
0.99%
0.99%
0.99%
0.99%
0.99%
0.99%
0.99%
0.99%
100.00%

The detected AMR genes confer resistance to the different drug classes by 5
different resistance mechanisms of a total 60 mechanisms, which represent 13.03% of
the overall detected resistance mechanisms. The most abundant detected AMR gene
families which represent 52.46% of all detected AMR genes were as follows, major
facilitator superfamily (MFS) antibiotic efflux pump (18.03%), Erm 23S ribosomal
RNA methyltransferase (13.11%), blaZ beta-lactamase (8.20%), APH(3'') (6.56%) and
APH(6) (6.56%). However, the first major five drug classes which represent 56.44% of
the 101 detected drug classes were as follows, aminoglycoside antibiotic (14.85%),
macrolide antibiotic (10.89%), lincosamide antibiotic (10.89%), streptogramin
antibiotic (10.89%) and fluoroquinolone antibiotic (8.91%). While the five detected
resistance mechanisms by which genes introduce drug resistance, were as follows;
antibiotic inactivation (35%), antibiotic target alteration (28.33%), antibiotic efflux
(23.33%), antibiotic target protection (10%) and antibiotic target replacement (3.33%).

The next samples from the last three selected metagenomes represent the
smallest fraction of all results. Their combined results gave less than 1% compared to
the rest of results. No perfect hits were detected and only few strict hits were reported
as follows, 3 hits, 1 hit and 1 hit from Nose, Tonga and Mangrove projects, respectively.
These results reflect a few number of detected AMR gene families (i.e. 3, 1 and 1 for
each projects on the same stated order, Nose, Tonga and Mangrove), which represent
only 0.49% from the whole results. The detected AMR gene families were as follows,
3 Erm 23S ribosomal RNA methyltransferase, 1 TEM beta-lactamase and 1 resistancenodulation-cell division (RND) antibiotic efflux pump for samples of Nose, Tonga and
Mangrove projects, respectively. Regarding the detected drug classes, we reported a
total of 15 drug classes from the three projects, Nose samples came in the first place by
9 classes, then Tonga with 4 classes and last place was for Mangrove samples with only
2 classes. These 15 drug classes represent 0.84% from the overall results (Tables 9 –
11). The nine drug classes of Nose project were from three different classes, macrolide
antibiotic, lincosamide antibiotic and streptogramin antibiotic which share the same
percentage 33%. While the four detected drug classes of Tong project were from four
different classes as follows; monobactam, cephalosporin, penam and penem. We also
reported only 2 drug classes from samples of Mangrove project as follows;
fluoroquinolone antibiotic and tetracycline antibiotic. Five resistance mechanisms,
represent 0.52%, were also reported from the three projects, 3 from Nose, 1 from Tonga
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and 1 from Mangrove. These five mechanisms belong to three different types as
follows; antibiotic target alteration, antibiotic inactivation and antibiotic efflux for
Nose, Tonga and Mangrove metagenomes, respectively.
Table 9. Drug classes detected by CARD's RGI in nose samples. A total 9 drug classes from 3
different classes, according to CARD’s classification were detected.
#
Drug Classes
Detected #
%
macrolide antibiotic
3
33%
1
lincosamide antibiotic
3
33%
2
streptogramin antibiotic
3
33%
3
GRAND TOTAL 9
100.00%
Table 10. Drug classes detected by CARD's RGI in Tonga trench samples. A total 4 drug classes from
4 different classes, according to CARD’s classification were detected.
#
Drug Classes
Detected #
%
Monobactam
1
25%
1
Cephalosporin
1
25%
2
Penam
1
25%
3
Penem
1
25%
4
GRAND TOTAL 4
100.00%
Table 11. Drug classes detected by CARD's RGI in Mangrove samples. A total 2 drug classes from 2
different classes, according to CARD’s classification were detected.
#
Drug Classes
Detected #
%
fluoroquinolone antibiotic
1
50%
1
tetracycline antibiotic
1
50%
2
GRAND TOTAL 2
100.00%
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Chapter 4: Discussion
According to WHO, antimicrobial resistance is considered one of the most
complex global health challenges and should be a political priority. Dr Chan, WHO
Former Director-General, said "The World Bank has warned that antimicrobial
resistance could cause as much damage to the economy as the 2008 financial crisis."
Moreover, with the limited choices of replacement products, WHO experts expect that
the world is heading toward a post antibiotic era and the common infectious diseases
will be mortal once again. This put a great pressure on the scientific community all over
the world to discover new classes of antibiotics with new mechanisms of actions against
the rising number of antimicrobial resistant bacterial strains.
Over the third of small molecule medicines approved by the FDA were microbial
natural products encoded by neighboring genes called Biosynthetic Gene Clusters
(BGCs) (Newman & Cragg, 2020 & Martin, 1992). To date, the gold standard way for
discovering bioactive natural products is the culture-dependent techniques which
considered a major challenge due to the fact that only small fraction of bacterial species
could be cultured under the current laboratory conditions (Stewart, 2012). The
advancement of sequencing technologies and omics approaches unleash the power of
natural products discovery through exploring the uncultivated microbial species which
represent the biggest fraction of microbial community. Here we tried to positively
contribute in solving the antimicrobial resistance problem by two different ways.
Firstly, we tried to support researchers who interested in natural products discovery
through catalog the bacterial BGCs in the selected metagenomes by conducting a
comparative analysis to determine the different BGCs’ classes present in each of the
selected samples along with highlighting the major bacterial species contributors.
Secondly, we did a thorough analysis to detect the antimicrobial resistance genes with
their resistance mechanisms along with the drug classes they confer resistance to, in
order to shed the light on this crises with deeper insights.
Different environments have different microbial taxa profile
Each environments comprise huge microbial communities live in complex
interactions that greatly impact our life. Therefore, such comparative studies aiming to
precisely profile the microbial communities’ compositions and their corresponding
contributions in terms of production of secondary metabolites, are of fundamental
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interest. Our results show that the different environmental conditions are the major
determinants of the microbial composition. By screening 65 samples from seven
different metagenomic and metatranscriptomic projects we discovered reads belong to
a wide range of different microbial taxa, at the genus level, and some of them was found
to be unique and characteristic to their corresponding environments. For example,
samples from Osaka bay project were characterized by the presence of three major
genera, in terms of their BGC contribution, the first place goes to Pseudomonas which
contribute alone by more than 60% of the detected BGCs, Synechococcus comes in the
second place by more than 15% while the third place goes to Candidatus Plagibacter
by about 4% of the detected BGCs. Moreover, Synechococcus was not recognized in
any other samples from the other 6 projects therefor it was unique and characteristic to
this environment at the time of sampling. Mangrove samples, on the other hand, were
characterized by the presence of two unique genera which not reported elsewhere in our
study, Altererythrobacter and Erythrobacter which contributed by about 10% and 8%
of the detected BGCs respectively. Candidatus, which appeared to be characteristic also
to Osaka bay environment, comes here in the third place contributing by about 6% of
the detected BGCs (Figure 16).

Figure 16. Distribution of the number of contributed genus to BGCs with their respective
contribution percentages as assigned by antiSMASH per dataset.
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Table 12 has a complete comparison between antiSMASH and deepBGC results in
terms of the detected BGC classes with their corresponding percentages and the most
abundant genera with their contributions’ percentages. It was obvious that each
environment had a signature microbial taxa profile, at the time of sampling, in terms of
the relative abundance and sometimes there is a unique genera specific to each particular
environments. In Tonga trench samples two genera were contributed the most to the
detected BGCs, Cutibacterium (~16%) and Pseudomonas (~4%) while Shewanella was
unique to this environment, although, it present in a relatively low abundance it survived
and this case and other similar cases will be explained with some details in the next
sections.
Table 12. Comparison between antiSMASH and deepBGC in terms of the detected BGCs’ classes with their
corresponding percentage and the most abundant genera with their percentage of contribution.

Projects

Osaka
Bay

COVID19

Skin
(AD)

BGC classes

antiSMASH
%
Genus

%

BGC classes

deepBGC
%
Genus

%

NRPS
Bacteriocin

44%
20%

82%
13%

Polyketide
NRP

49%
13%

63%
15%

Terpene

9%

RiPP

12%

Pseudomonas
Synechococcus
Candidatus
Plagibacter

Arylpolyene
NRPS-like
Siderophore

7%
7%
5%

8%
7%
6%

hserlactone

5%

betalactone

3%

NAGGN

1%

sactipeptide
NRPS
bacteriocin
arylpolyene
lanthipeptide
NRPS-like

28%
19%
16%
12%
7%
5%

Bacteroides
Blautia
Lachnospiraceae
Faecalibacterium

16%
7%
5%
5%

Terpene

2%

T3PKS

2%

lassopeptide

2%

Other
Saccharide
Terpene
SaccharideTerpene
PolyketideTerpene
NRPPolyketide
Polyketide
Saccharide
RiPP
Other
NRP
Terpene
PolyketideTerpene
NRPPolyketide
SaccharideTerpene

Betalactone
Resorcinol
Siderophore
Thiopeptide
Nucleoside
butyrolactone
Ladderane
NRPS
NRPS-like
Siderophore
Terpene
Bacteriocin
T1PKS

2%
2%
2%
0.4%
0.4%
0.4%
0.4%
27%
17%
10%
10%
9%
8%

46%
14%
10%
10%
8%
5%

Gordonia
Corynebacterium
Mycolicibacterium
Cutibacterium
Micrococcus

16%
14%
7%
7%
7%

Ectoine

4%

T3PKS

3%

Hserlactone

3%

Polyketide
RiPP
Saccharide
NRP
Other
Terpene
PolyketideTerpene
SaccharideTerpene
NRPPolyketide

Pseudomonas
Synechococcus

Blautia
Lachnospiraceae
Bacteroides
Faecalibacterium
Streptococcus

Gordonia
Corynebacterium
Cutibacterium
Staphylococcus
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13%
12%
7%
6%
5%

24%
15%
12%
6%

4%

3%
2%
1%
30%
26%
23%
11%
4%
3%
1%
1%
0.13
%

5%
2%
1%

Tonga

Mangrov
e

Skin
(Nose)

Sewage

Thiopeptide
Betalactone
lanthipeptide
Arylpolyene
CDPS
LAP
hglE-KS
Ladderane
butyrolactone
lassopeptide
Arylpolyene
NRPS-like
hglE-KS
Bacteriocin
phosphonate
Terpene

2%
1%
1%
1%
1%
1%
1%
1%
0.4%
0.4%
17%
17%
17%
13%
9%
9%

Hserlactone

9%

T1PKS

4%

NRPS
Bacteriocin
Arylpolyene

4%
33%
17%

NRPS-like
Terpene
lassopeptide
NRPS

17%
17%
8%
8%

NRPS

39%

Terpene
Siderophore
NRPS-like
T1PKS

22%
22%
9%
9%

Bacteriocin
Terpene
hserlactone
NRPS-like
arylpolyene
sactipeptide

30%
28%
10%
8%
7%
5%

resorcinol

3%

T3PKS

3%

Ectoine
butyrolactone
phenazine
RaS-RiPP

2%
2%
1%
1%

Shewanella
Unique genus and
produce unique
product
(phosphonate)

-

NA

-

Corynebacterium

Streptococcus
Neisseria
Polaromonas
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Polyketide
RiPP
Terpene
Other
NRP
Saccharide
PolyketideTerpene
SaccharideTerpene
NRPPolyketide
Polyketide
Saccharide

52%
12%
11%
8%
7%
5%

NRP
RiPP
Other
Terpene
PolyketideTerpene
SaccharideTerpene
NRPPolyketide

11%
9%
8%
6%

100
%

Polyketide

27%
15%
6%

RiPP
Other
NRP
Saccharide
Terpene
PolyketideTerpene
NRPPolyketide
Polyketide
RiPP
Saccharide
Other
NRP
Terpene
PolyketideTerpene
NRPPolyketide
SaccharideTerpene

Cutibacterium
Pseudomonas

16%
4%

Altererythrobacter
Erythrobacter
Candidatus
Plagibacter

10%
8%

Corynebacterium

78%

Escherichia
Acidovorax
Neisseria
Streptococcus
Arcobacter
Pseudomonas

9%
6%
5%
4%
3%
3%

4%
1%
1%
46%
13%

6%

5%
1%
0.4%
45%
17%
12%
9%
8%
7%
1%
1%
44%
17%
15%
12%
5%
4%
2%
1%
0.3%

It was expected that similar environments in terms of their nature, most probably
would have similar microbial composition. This was reported in our study as follows,
samples from two different skin environments were addressed; samples of the Human
skin metagenome from epithelium of external nose project were characterized and
dominated by Corynebacterium while the samples from metagenomic skin of patients
with AD were characterized by the following genera, Corynebacterium and
Cutibacterium. Here Corynebacterium was the first contributors in both skin
environments by more than 75% and about 14% of the detected BGCs in nose & skin
AD samples respectively. Cutibacterium comes in the second place in terms of BGCs
contribution by about 7% in skin AD patients samples and this might be due to an arm
race between Corynebacterium and Cutibacterium and both genera were trying to create
their own niche at the time of sampling. Three water in nature environments, Osaka,
Tonga and Sewage, also were characterized by the presence of Pseudomonas genera
with a high relative abundance in Osaka bay and very low abundance in both Tonga and
Sewage samples. Moreover, samples from both COVID-19 patients and sewage
represent gut microbiome community and this could explain the presence of
Streptococcus genera in both samples. The Barplot in Figure 4 in results section,
showing the relative abundance of all the detected microbial taxa, at the genus level, of
the 65 processed samples per each of the seven selected projects.
Our analysis also shows that there might be common bacterial strains between
irrelevant environments, such as the presence of Cutibacterium in samples from both
skin AD patients and Tonga trench. Moreover, we reported the presence of Candidatus
in both samples from Osaka bay and Mangrove with relatively low abundance in both.
To show how the different samples will be clustered based on the relative abundance of
taxa we constructed both a PCA and t-SNE graphs (Figures 5 & 6 in results section).
Projects like Osaka bay and water sewage which dominated by Pseudomonas and
Streptococcus respectively with a high abundance, appeared completely separated from
the rest five projects, while there were many connections between the other projects,
which mainly due to the presence of common genera, such as Corynebacterium and
Cutibacterium which explained the presence of some samples, appeared on both figures
as colored dots, from the Human skin metagenome from epithelium of external nose
and Tonga trench project around the samples of the skin project of AD patients (Table
12).
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It was also obvious that samples of some projects were dominated by few unique
genera such as the samples from Osaka bay project which were dominated mainly by
Pseudomonas with very large percentage followed by Synechococcus with relatively
high percentage. Moreover, samples from the project of metagenomic skin of patients
with AD were dominated mainly by Cutibacterium which is characteristic to skin
environment, while Corynebacterium stands alone in the samples of the Human skin
metagenome from epithelium of external nose project. Species like Streptococcus
agalactiae were unique and characteristic to the samples of the water sewage projects.
Although Streptococcus agalactiae present in a very low abundance it survived at the
time of sampling. To understand the reason behind the presence of different microbial
profiles in each environments, where some genera stands alone in some samples while
there are samples with many different species live together and how could some species
survive with a very low abundance, we analyzed the microbial biosynthetic potential of
each environment on the next section.
The biosynthetic potential of the selected microbial metagenomes
The importance of secondary metabolites came from their potential applications,
as assigned by deepBGC the vast majority, about 95%, of the detected BGCs have an
antibacterial activity. According to antiSMASH results, 45 out of 65 samples from the
seven selected projects give hits of a total 776 BGCs regions of different 26 classes. We
found that the number of BGCs and their classes directly proportional with the degree
of microbial diversity (Figure 17).

Figure 17. Distribution absolute number the different BGCs classes detected by antiSMASH per
dataset.
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Environments with a high degree of microbial diversity such as skin AD, gut
microbiome of COVID-19 patients and sewage were very rich in terms of total number
of detected BGCs and also in the number of BGCs’ classes. Ten samples from skin AD
come in the first place with 272 detected BGCs belong to 19 different classes with 2
unique classes (i.e. CDPS & LAP) which not reported elsewhere in our study. About
57% of the detected BGCs belongs to four genera, Gordonia, Corynebacterium,
Cutibacterium and Staphylococcus. There might be an arm race between these genera
and each one trying to use as many weapons (i.e. SMs) as they can to create their own
niche. Figure 18 showing BGC hits detected by antiSMASH boxplot for each dataset,
in relation to its assigned genus.

Figure 18. BGC hits detected by antiSMASH boxplot for each dataset, in relation to its assigned genus.
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The majority of the detected BGCs has antimicrobial activity such as NRPS,
represents 27% of BGCs, which was reported to have antibacterial activity and one
major example of this group is β-lactams and some has also an antitumor activity
(Felnagle et al., 2008). Terpene, bacteriocin, T1PKS, T3PKS, thiopeptide, betalactone,
lanthipeptide, LAP and lassopeptide are also examples of such classes with an
antimicrobial activity. On the other hand there should be a dialog and some sort of
coordination between the community members through quorum sensing, this could be
explained by the presence of homoserine lactone cluster (hserlactone) which known to
has a rule in quorum sensing (Churchill et al., 2011). Butyrolactone also was detected
which considered a type of signaling molecules that manage group of genes involved in
the bacterial specialized metabolism and morphological differentiation (Horinouchi et
al., 2001). Table 13 has more example of the potential use of the secondary metabolites
detected in our analysis.
Table 13. Potential application of some detected secondary metabolites

BGC class

Potential application

Reference

NRPS

Felnagle et al., 2008

Saccharides

The majority has antibacterial activity (e.g. β-lactams) and
antitumor effect (e.g. bleomycin)
Some have antibacterial activity

Terpene

Subgroup of terpenes have antibacterial activity

Polyketides
(T1PKS)
Polyketides
(T3PKS)

Subgroup of T1PKS are involved in antibiotic synthesis (e.g.
erythromycin)

Yu et al., 2012

Antibacterial and antitumor activity

Lim et al., 2016

Phosphonate

Have antibacterial activity (e.g. fosfomycin)

Ectoine

Have a potential use in prevention of Alzheimer’s
Can produce peptides involved the control of a quorum sensing
(QS) system
Has a role as cell signals that regulate patterns of gene expression
Peptidic toxins inhibit the growth of similar or closely related
bacterial strains
Antioxidants which protect the bacteria from reactive oxygen
species.

Ras-RiPP
Phenazine
Bacteriocin
Arylpolyene
Siderophore

Responsible mainly for iron transportation across cell membranes

Hserlactone

Quorum sensing

NAGGN

Contribute to bacterial cell survival

RiPP

Betalactone
Sactipeptide
Lanthipeptide
Lassopeptide

Has more than 20 sub-classes with many applications (i.e.
Antibiotics, food preservative, animal feed additives and in cell
biology anantin is used as an atrial natriuretic peptide receptor
inhibitor)
β-lactones appear in different NP classes, such as PKs,
nonribosomal peptides and terpenoids. It has inhibition activities
for ligases, transferases, oxidoreductases and hydrolases.
A member of bacteriocin class I which has antimicrobial activity.
A member of bacteriocin class I which has antimicrobial activity.
A member of bacteriocin class I which has antimicrobial activity.
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Weitnauer et al., 2001
Brahmkshatriya &
Brahmkshatriya, 2013

Metcalf & van der Donk,
2009
Jorge et al., 2016
Ye et al., 2020
Pierson & Pierson, 2010
Cotter et al., 2013
Carter, J.; et al., 2016
Cornelis P & Andrews
SC, 2010
Churchill et al., 2011
Matthias Kurz et al.,
2010
Arnison PG et al., 2013
Wyss DF et al., 1993
Robinson et al., 2018
Lehmann et al., 2018
Arnison PG et al., 2013
Arnison PG et al., 2013
Arnison PG et al., 2013

Resorcinol
Thiopeptide
Nucleoside
Butyrolactone
Ladderane
LAP
hglE-KS

Has a structural roles in membrane formation and associated with
wide biological activities such as antibacterial, cytotoxic,
dermatotoxic, antioxidant and genotoxic
Has antimicrobial activity against several drug-resistance
pathogens
Could inhibit bacterial RNA polymerase and has antibacterial
activity against drug-resistance bacteria
Type of signaling molecule that manages group of genes
involved in the bacterial specialized metabolism and
morphological differentiation.
Potential biofuel
Has antibacterial activity
Type of Polyketide synthases (PKS) which has many
pharmaceutical activities such as antibacterial, antifungal &
antitumor.

H. Kikuchi et al., 2017
R Liao et al., 2009
SI Maffioli et al., 2017
Horinouchi et al., 2001
Javidpour, P et al., 2016
DY Travin et al., 2019
Jenke-Kodama et al.,
2005

Another example of such complex and diverse environment is COVID-19 patients’
samples. Five genera, Blautia, Lachnospiraceae, Bacteroides, Faecalibacterium and
Streptococcus contribute by about 43% from a total number of 243 detected BGCs
belong to 16 different classes. Nucleoside which could inhibit bacterial RNA
polymerase and has antibacterial activity against drug-resistance bacteria, was unique
to this environment (SI Maffioli et al., 2017). Gut microbiome of COVID-19 patients’
samples also were characterized by the presence of a wide array of bacteriocin, peptidic
toxins which have the ability to inhibit the growth of similar or closely related bacterial
strains (Cotter et al., 2013) in addition to the presence of sactipeptide, lanthipeptide and
lassopeptide which considered members of bacteriocin class I which have antimicrobial
activity (Arnison PG et al., 2013). Moreover, thiopeptide was also detected which has
an antimicrobial activity against several drug-resistance pathogens (R Liao et al., 2009).
Figure 19 is a heatmap for each dataset with each of the BGC hits from antiSMASH in
relation to its assigned genus.
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Figure 19. Heatmap for each dataset with each of the BGC hits from antiSMASH in relation to its
assigned genus.

Sewage samples comes in the third place in terms of the number of detected BGCs with
a total of 102 BGCs belonging to 12 different classes. Here about 50% of the detected
BGCs comes from 3 different genera, Streptococcus, Neisseria and Polaromonas.
Different BGCs classes with antimicrobial activity were detected such as bacteriocin,
terpene, NRPS-like, sactipeptide and T3PKS. This environment was characterized also
by the presence of many signaling and regulating classes such as hserlactone,
butyrolactone, phenazine and RaS-RiPP. The last two classes were unique to this
environments where phenazine, has a role as cell signals that regulate patterns of gene
expression (Pierson & Pierson, 2010) while RaS-RiPP, a product of Streptococcus
Agalactiae, can produce peptides involved in the control of a quorum sensing (QS)
system (Ye et al., 2020). On the other hand, phenazine could be a good example to
prove that some species might produce new metabolites under different environmental
conditions, in this study we noticed that Escherichia coli from sewage water samples
only produce phenazine in such environment and we didn’t recognize this elsewhere
from any other projects.
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Many other BGCs’ classes were detected in other samples such as saccharides which
also have antibacterial activity especially the subset which has a cellular diffusible
ability (Weitnauer et al., 2001). Type 1 Polyketides were reported to be involved in
antibiotic synthesis such as erythromycin and oxytetracycline (Yu et al., 2012), while
type 3 Polyketides were known about their antibacterial and antitumor activities (Lim
et al., 2016).
In this study, some environments such as Tonga trench doesn’t have a signature
microbial composition. However, the genus Chewanella was characteristic to this
environment by producing a unique product (i.e. Phosphonate) which had been reported
to have antibacterial activity and one famous example is fosfomycin (Metcalf & van der
Donk, 2009), at the time of sampling, this species might started to fight to create its own
niche. This could be studied over a course of time to detect the environmental microbial
composition change over time.
Comparison of BGCs as detected by DeepBGC and antiSMASH
By using both pipelines we noticed some major differences between them and
could be summarized in the following points; antiSMASH was more power in detecting
the exact BGC class, on the other hand, deepBGC detects a huge amount of BGCs
compared to antiSMASH. A total 776 BGCs were detected by antiSMASH from the
selected projects and only 45 samples from 65 processed samples gave hits, while
deepBGC detected large number of BGCs, a total 79,771 BGCs were detected from the
selected projects, moreover all the 65 samples gave hits. AntiSMASH detected 26
different BGC classes and the seven major classes detected in this study which
collectively represent about 80% of the total detected BGCs classes were NRPS (23%),
bacteriocin (15%), NRPS-like (10%), terpene (10%), sactipeptide (9%), arylpolyene
(7%) and siderophore (5%). On the other hand, deepBGC assigned BGCs classes to
only around 20% of hits (15,714 hits) as follows; 39% of hits was Polyketide, 18%
RiPP, 18% Saccharide, 10% others, 7% NRP, 4% Terpene, 2% Polyketide-Terpene, 1%
NRP-Polyketide and 1% Saccharide-Terpene. Although deepBGC could annotate only
six classes (i.e. Alkaloid, NRP, Polyketide, RiPP, Saccharide and Terpene), however it
has a major advantage as it could assign product activity to each single detected BGC
class with a very high coverage rate (Figure 20). In this study deepBGC assigned
product activity to 96% of the hits and the results were 97% of hits have an antibacterial
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activity, 1% inhibitor, 1% antibacterial-antifungal and less than 1% cytotoxic. Table 5
had a detailed comparison between antiSMASH and deepBGC in terms of the detected
BGC classes with their corresponding percentage and the name and percentage of the
most abundant contributed genera.

Figure 20. BGC hits detected by DeepBGC (product activity assigned) boxplot for each dataset,
in relation to its assigned genus.

AMR genes profile of samples in the dataset as detected by CARD’s RGI
Around 700,000 deaths yearly due to infection by resistant microbes (O’Neill
(chair) J., 2014). According to ECDC, the European Center of Disease Prevention and
Control, antimicrobial resistance infections cause every year around 23,000 and 25,000
deaths in the US and Europe, respectively (CDC infographic, 2019). Such figures
mandate the need of novel natural products discovery with novel mechanisms of action.
To reach this goal, we tried to contribute in the first part of our study through catalog
the BGCs of different bacterial species from the selected metagenomes as this would
help a lot in understanding the dynamics of SMs between related or different microbes
and hopefully this would help. In the same context, the second major goal of this
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research was to detect the antimicrobial resistance genes of the samples from the
selected metagenomes, along with their mechanisms of actions and the drug classes
which it confers resistance to. This also would greatly help to understand the different
factors affecting the development of resistance and the possibility of spreading this
resistance between closely related or even different bacterial strains through Horizontal
Gene Transfer (HGT). Here we used Resistance Gene Identiﬁer (RGI) algorithm from
The Comprehensive Antibiotic Resistance Database (CARD) for AMR genes detection.
From the sixty five processed samples from the different seven selected metagenomes,
CARD’s RGI recognized a total number of around 1216 AMR gene families which
confer resistance to about 2602 drug classes by 1163 resistance mechanisms. The largest
percentages of results, more than 70%, were from the samples of both gut microbiome
of COVID-19 patients and water sewage (Figures 8 – 10) and they also share many of
aspects as follows; among the fifty five and thirty seven different AMR gene families
of gut microbiome of COVID-19 patients and water sewage, respectively, the first
major two AMR gene families were resistance-nodulation-cell division (RND)
antibiotic efflux pump and major facilitator superfamily (MFS) antibiotic efflux pump
they represent the highest percentages; 45.75% and 45.65% of gut microbiome of
COVID-19 patients and water sewage samples, respectively. Therefore, the major
resistance mechanism in both samples was antibiotic efflux which represents 47.93%
in gut microbiome of COVID-19 patients’ samples and 45.38% in water sewage
samples. Although, gut microbiome of COVID-19 patients’ samples comes in the first
place in the number of the detected drug classes, 1378 drugs of different 32 classes, and
water sewage comes next with 1031 drugs from different 29 classes, they were also
relatively similar in terms of kind of drug classes. The first three major drug classes
detected in both samples were tetracycline antibiotic, fluoroquinolone antibiotic and
penam which collectively represent around 35.92% and 36.95% of all detected drug
classes from gut microbiome of COVID-19 patients and water sewage samples,
respectively.
The rest of samples from the other projects show also similar results with a very
low abundance compared to gut microbiome of COVID-19 patients’ samples and water
sewage samples. Antibiotic efflux pump AMR gene families both RND and MFS also
represent the highest percentages; they represent 58.33% & 19.67% of all detected
AMR gene families of Osaka and skin AD samples, respectively. However, there was
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a slight difference in the order of resistances mechanisms between them, antibiotic
efflux comes in the first place and represents 51.61% of the three detected mechanisms
of Osaka samples while antibiotic inactivation comes first by 35% and antibiotic efflux
was in the third place by 23.33% from the five different detected resistance mechanisms
of skin AD patients samples. Moreover, the major drug class detected in both samples
was aminoglycoside antibiotic by 14.85% and 12.99% from skin AD and Osaka
samples, respectively. The results of the last samples from the rest three metagenomes,
Nose, Tonga and Mangrove, represent the smallest fraction of all results. Their
combined results were less than 1% compared to the rest of results. No perfect hits were
detected and only few strict hits were reported as follows, 3 hits, 1 hit and 1 hit from
Nose, Tonga and Mangrove projects, respectively.
The effect of antibiotic use in AMR genes transfer between microbial communities
We tried to find a connection between the detected BGCs in the first part of our
study and AMR genes detected by CARD. Although, the ten samples of skin AD
patients were the first among the rest metagenomes in terms of the number of detected
BGCs, 272 BGCs from 19 different classes, it comes in the 4th place in terms of the
normalized percentage of detected AMR genes after the samples of gut microbiome of
COVID-19 patients, Sewage and Osaka metagenomes. Therefore, another reason other
than the degree of microbial diversity should be responsible for putting the microbial
communities under stress and bush them to share their resistance genes horizontally.
This might be the reason behind the high abundance of the detected AMR genes, around
70%, from gut microbiome of COVID-19 patients and water sewage samples. To
eliminate the effect of sample size on results, this percentage was normalized to the total
number of bases per each project. Results show a degree of similarity between both
samples, this might be due to a common factor drives their respective bacterial
communities toward sharing their AMR genes. Microbial communities of both gut
microbiome of COVID-19 patients’ samples and water sewage sample exposed to
abroad spectrum of antibiotics from different classes with different doses, such common
factor would be of a great impact on the development of a huge number of highly
resistant bacterial strains. In the next part, we will try to highlight some important results
from both environments and trying to relate this to the recent researches.
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AMR genes in gut microbiome of COVID-19 patients’ samples
Regardless the fact that COVID-19 is a viral infection, many people around the
world in low, middle and also high-income countries think that the use of antibiotics
would help in the treatment and/or prevention of infection. In the same context and
according to the European division of WHO, there were results of behavioural insight
research from nine European countries prove that the antibiotic use increasing along
with cases throughout the pandemic, around 79 – 96% of those taking antibiotics, were
reported not infected with COVID-19 but they believe that the use of antibiotics is the
proper preventive action. Moreover, results show that 75% of COVID-19 patients used
antibiotics while only 15% of them develop bacterial co-infection and could need
antibiotics (WHO, 2020). On the other hand, in Italy when the pandemic strikes,
according to Dr Nino Berdzuli, Director of WHO/Europe’s Division of Country Health
Programmes, they gave COVID-19 patients broad spectrum antibiotics such as
cephalosporins and azithromycin, this was the routine treatment of community-acquired
pneumonia cases. To date, azithromycin still used as the first choice antibiotic in such
cases worldwide on the basis of its immunomodulatory action. Here we reported that
about 15% AMR genes confer resistance to cephalosporin and macrolide antibiotic
drugs classes, azithromycin belongs to macrolides, and this would show a direct relation
between the use of antibiotics and the development of antimicrobial resistance. A recent
recovery trial in the UK published on 14 December, 2020 shows that azithromycin with
no benefit to patients hospitalized with COVID-19. In this trial a total 2582 patients
taking azithromycin were compared to 5182 patients randomized to the usual care alone
(Horby et al., 2020). The situation is even worse, a study published on March, 2020
conducted in intensive care units from 88 countries on total 15165 COVID-19 patients,
showed that 70% of them received antibiotics, at least one, for treatment or even
prophylaxis purposes where only 54% of them had proven bacterial co-infection
(Vincent JL et al., 2020). The wide use of biocidal agents as disinfectants in nonclinical, would be another possible threat. It has been reported that even the low
exposure to these agents leads to the selection of drug resistance microorganisms,
particularly gram negative bacteria (Kampf G., 2018). Our results showed that gut
microbiome of COVID-19 patients’ samples were the first among the selected
metagenomes in terms of number of detected hits with total 544 hits. Moreover, it has
the highest percentage of detected AMR gene families (48.26%) of different 55 families
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which confer resistance to around 51.51% of drugs from different 37 classes by six
different mechanisms. This might explain the reported fatal co-infection by
exceptionally antibiotic resistance bacteria in gut microbiome of COVID-19 patients
(Sharifipour E. et al, 2020). There should be a strict regulation from the health
authorities around the world to avoid using antibiotics in cases where no sign of
bacterial co-infection.
AMR genes in water sewage
Although, spread of antimicrobial resistance is a global clinical concern, this
issue is not limited to the clinic. Antibiotics used by humans will at the end of the day
end up in sewage, therefore waste water considered one of the biggest reservoir of
antibiotics, AMR genes and bacterial from diverse sources and waste water treatment
plants are usually one of the main sources of antibiotic-resistance bacteria and AMR
genes spread into the environment (Rizzo, L. et al., 2013). In our study, we reported
466 hits from all samples of water sewage, 96 of hits were perfect and 370 were strict
hits. This represents 23.37% of the detected AMR gene families from different 37
families which confer resistance to 22.42% drugs from different 29 classes with
different 6 resistance mechanisms. Waste water considered a hotspot of spreading
resistance genes not only between closely related bacterial strains but also this could be
happen between phylogenetically distant strains (Jiang, X. et al, 2017) this might be due
to the selection pressure caused by pollutant compounds such as heavy metals,
antimicrobial agents, biocides and drugs which could promote horizontal gene transfer
(Aminov, R.I, 2011). Such selection pressure is a significant issue in the presence and
spreading of AMR genes in sewage. Whenever there is a selection pressure for
antimicrobial resistance bacteria, they overgrow the sensitive ones and they can share
their resistance genes, which are usually included in mobile genetic elements (MGE),
through one of the three major mechanism, transformation, transduction and
conjugation (Karkman A et al., 2018). We reported here relatively big numbers of AMR
gene families, 55 from gut microbiome of COVID-19 patients’ samples and 37 from
water sewage, which confer resistance to many drug classes, 37 and 29, from gut
microbiome of COVID-19 patients’ samples and water sewage samples, respectively.
This could be explained by the fact that each MGE usually contains AMR genes for
more than on antimicrobial compound. Therefore, AMR gene could be selected by a
wide array of antibiotics which is the case in both environments. Moreover, the same
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MGE might also contain AMR gene for heavy metal or disinfectant, this can also lead
to a selection pressure for transferring antibiotic resistance between different bacterial
species (Karkman A et al., 2017). Waste water contributed the most in transmission of
AMR genes. Results from 63 studies, published between 2009 and 2019, were reviewed
elsewhere, confirming the presence of wide range of AMR genes and antibioticresistance bacteria in waste water around the world (Fouz N. et al., 2020).
Antibiotic efflux resistance mechanism in gut microbiome of COVID-19 patients’
and water sewage samples
In bacterial drug efflux pumps have many functions other than their key role in
drug resistance and there are escalating number of multiple drug efflux pumps reported
from bacteria isolated from different ecological samples (Li X-Z and Nikaido H, Drugs,
2009). In the current study, antibiotic efflux was the major detected resistance
mechanism from both gut microbiome of COVID-19 patients’ and water sewage
samples. It comes in the first place by 47.93% and 45.38% of the total detected
resistance mechanisms from gut microbiome of COVID-19 patients and water sewage
samples, respectively. It has been reported that efflux mediate drug resistance usually
acts concurrently with other resistance mechanisms which reflects higher resistance to
abroad spectrum of drugs. On the other hand, expression of drug pumps usually induced
by many molecules such as antimicrobial agents, bile salts and biocides (Li X-Z and
Nikaido H, Drugs, 2009), coupled with the fact that resistance genes usually present on
plasmids and other mobile genetic elements, the possibilities of their induction and
transfer between other bacteria in both gut microbiome of COVID-19 patients and waste
water are very high. It has been reported that aminoglycosides and macrolides induce
the expression of MexXY efflux pumps in P. aeruginosa (Jeannot K et al., 2005).
Fluoroquinolones were also responsible of induction the expression of both AcrAB and
PatAB pumps in S. pneumonia (Marrer E et al., 2006).
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Chapter 5: Conclusions and Future Perspectives
Conclusions
This study has two main objectives. Firstly, the assembled contigs were
investigated by two major distinct computational methods, namely antiSMASH and
deepBGC methods. A comparative study was performed to determine BGCs present in
each of the included samples, as well as comparing their taxonomic differences.
Secondly, the assembled contigs were also analyzed to determine AMR genes present
in each samples by using RGI algorithm which is a part of CARD. A total number of
sixty five samples pertaining to seven selected metagenomic / metatranscriptomic
projects were assembled, a total 1,139,543,039 reads were filtered to 1,100,630,009
filtered reads and the obtained reads and assembled contigs (4,325,515 contigs) were
subjected to taxonomic assignment. All assemblies were then investigated by two
different computational tools in addition to CARD, the first tool was antiSMASH, the
second tool was deepBGC and finally we used CARD to determine AMR genes in each
ecosystem.
To determine BGC content in each environment, our first goal, both
computational tools, antiSMASH and deepBGC, were run in parallel for BGC mining.
Although both tools were complementary to each other, however, there were major
differences between them, generally in terms of total number of the detected BGCs and
the number of annotated BGC classes. AntiSMASH detected only 776 BGCs which
represents less than 1% of the total number of detected BGCs by deepBGC (79,771
BGCs). However, antiSMASH showed a higher accuracy in detecting the exact classes
of BGCs and a higher annotation level. In this study antiSMASH annotated 26 different
classes of BGCs compared to only 6 fixed classes annotated by deepBGC (i.e. Alkaloid,
NRP, Polyketide, RiPP, Saccharide and Terpene) in addition to one extra unknown class
named “other”. A major advantage of deepBGC was its ability to assign product activity
to more than 95% of hits regardless the fact that only 20% of hits were got BGC class
annotation by deepBGC. The majority of product activities assigned by deepBGC were
97% antibacterial, 1% inhibitor, 1% antibacterial-antifungal and less than 1% cytotoxic.
For more detailed comparison between antiSMASH and deepBGC in terms of the
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detected BGC classes with their corresponding percentage and the name and percentage
of the most abundant contributed genera, see (Table 5).
The taxonomical assignment were of great impact to understand the dynamics
of SM production and the differences of BGCs classes detected from the different
environments. We clustered all samples based on their relative abundance of taxa and
their microbial composition by both PCA and t-SNE tools (Figures 5 & 6). Some
samples from the same projects had a characteristic relative microbial abundance so
they appeared nicely separated from the rest of samples such as the samples from both
Osaka bay project which dominated mainly by Pseudomonas and water sewage project
which had a very high relative abundance of and Streptococcus. Although, these two
environments dominated mainly be one genus and it was expected to have a slightly
low range of BGCs and if there a unique class of BGCs will be produced by other
predominated genera to protect their niche, however, Pseudomonas from Osaka project
produced a class of BGCs called N-γ-acetylglutaminyl glutamine 1-amide (NAGGN),
has a role in bacterial cell survival (Matthias Kurz et al., 2010) and it was not detected
elsewhere from any of the selected samples from all other projects, Streptococcus also
from water sewage project produced Ras-RiPP, has a role in quorum sensing, which
also was not detected in any other samples. Such examples are good evidence that, also
microorganisms have characteristic behavior, however, it might behave in a different
ways under different environmental conditions. This needs further investigations of
such environments over a course of time to see how their behavior changes over time,
could be a clear limitation of this study.
On the other hand, we also expect to detect unique classes from some species
which present in a very low abundance in some environments, here we reported two
cases. In Tonga trench project antiSMASH detected a BGC class called phosphonate
which was belonging to a genus called Shewanella which existed in a very low relative
abundance compared to Cutibacterium. The second example was from the water sewage
project, BGC class called phenazine was detected by antiSMASH and it was produced
by E. coli which exhibits a low relative abundance compared to Streptococcus.
We also noticed that the samples which had a large extent of variability (i.e. sex,
age and illness state) due to the nature of their environments, such as microbiome
samples of patients in two projects (COVID-19 & Atopic Dermatitis), gave the most
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variable number of BGC classes detected by antiSMASH, where 19 different classes
detected in skin microbiome of AD patients and 16 different classes detected in gut
microbiome of COVID-19 patients’ samples while the third place in terms of total
number of detected classes went to the water sewage project with 12 different classes
detected and this could be also due to the same reason. AntiSMASH did not detect more
than 10 different classes in the rest of projects.
The second goal of this study was to determine the AMR genes in the selected
metagenomes using CARD’s RGI algorithm. Due to the selection pressure on the
microbial communities by the wide use of antibiotics, gut microbiome of COVID-19
patients’ and water sewage samples had more than 70% of the detected AMR gene
families as detected by RGI. Gut microbiome of COVID-19 patients’ samples came in
the first place among the seven selected metagenomes by almost 50% of the total
detected AMR genes, while samples of water sewage came in the second place by
almost 25%. This might be a logical result of the misuse of antibiotics all over the world
as the majority of people believe this could help in the prevention or treatment of the
infection, as reported in many studies. In addition to the misuse of antibiotics, the wide
use of disinfectants for environmental and personal hygiene was also a potential reason
of spreading of antimicrobial resistance genes between different bacterial species.
Under specific harsh conditions bacterial species behave in adaptive way to survive.
One major mechanism, by which the resistant bacterial species would help the sensitive
ones to survive is through sharing their resistance gene horizontally by well-known
mechanism called horizontal gene transfer (HGT). Mobile genetic elements, transferred
during HGT, such as plasmids often contain resistance genes for more than one
antibiotic, moreover, in some cases the same element might contain resistance gene for
a specific metal or disinfectant. Consequently, such resistance genes might be selected
by the use of wide range of antibiotics, disinfectant and heavy metals. This applied to
both environments (i.e. gut microbiome of COVID-19 patients and water sewage)
because antibiotics and the other pharmaceutical drugs consumed by humans will
eventually end up in sewage.
Recent studies conducted on COVID-19 patients globally show the improper
use of antibiotics along with many cases of fatal co-infection with highly resistant
bacterial strains. In our study, gut microbiome of COVID-19 patients’ samples harbor
bacterial species resistant to 37 different classes of antibiotics. About 15% of the
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detected AMR genes were resistant to the two major antibiotic classes used in COVID19 infection, cephalosporins and macrolides. Despite the fact that the majority of cases,
even if they are diagnosed as positive COVID-19, don’t need antibiotics as long as there
is no sign of bacterial infection, 75% of patients take antibiotics. On the other hand, a
recovery study conducted in the UK revealed that the use of azithromycin with COVID19 patients was with no effect compared to patients with same conditions randomized
on the routine treatment without azithromycin.
Overall, diverse environments harbor different microbial composition with
dissimilar relative abundance of taxa and this leads to the presence of a wide variety of
secondary metabolites in each environments in addition to the presence of a wide range
of AMR genes in environments under specific selection pressure such as gut
microbiome of COVID-19 patients’ and water sewage samples. Environments with
high microbial diversity such as host microbiome (i.e. skin AD & gut COVID-19)
harbor large percentage of BGCs, maybe due to the arms race between co-existing
microorganisms. Both antiSMASH and deepBGC complemented each other to get a
clearer picture about the nature of different environments in terms of the relative
microbial abundance and their corresponding BGCs content. In addition to the degree
of microbial diversity, environments under specific selection pressure by antibiotics,
disinfectants and heavy metals, had the biggest percentages of AMR genes. COVID-19
and water sewage harbor more than 70% of AMR genes detected by CARD’s RGI.
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Future Perspectives
There is no question that there is an escalating interest to investigate biosynthetic
pathways to discover new natural products. Environments with rich microbial diversity
such as host microbiome and marine ecosystems should be thoroughly mined for
biosynthetic gene clusters and antimicrobial resistant genes using different
computational tools in order to find explanation on how novel secondary metabolites
are assembled and which microorganisms carry AMR genes and to what extent they are
mobile. The information in this study will be of great value to other researchers who
interested in either isolation of natural products or studying the antimicrobial resistance
mechanisms. In addition to their therapeutic use, understanding the dynamics of
secondary metabolites is crucial for studying different microbial populations and their
effects on substance turnover.
On the other hand, a time dimension could be a major limitation to this study,
sampling over a course of time is critical to clearly understand the dynamics in each
ecosystem. Few cases of interest were reported, we detect many SMs with antibacterial
activity belonging to some genera, present in a relatively low abundance in highly
diverse ecosystems, such as Pseudomonas from Osaka and Streptococcus from sewage
water, they might be under stress and were trying to fight to create their own niche by
producing their own weapons (i.e. SMs) at the time of sampling but we do not know
how the situation could be changed over time. Moreover, the use of antibiotics and other
factors such as disinfectants shift microbial populations toward sharing their resistance
genes. Therefore, monitoring microbial environments over a course of time is very
crucial to understand the microbial behavior under different conditions such as high
competition and other stress environmental conditions such as antibiotics, disinfectants
and heavy metals.
Many evidences suggested that, the misuse of antibiotics has a direct
contribution to the global widespread of antibiotic resistance. In this study, samples
from gut microbiome of COVID-19 patients from Hong Kong showed very interesting
results, it harbors the largest percentage of AMR genes, more than 50% of the detected
AMR genes in all datasets. Many factors might be contributed to such results, it would
be very important to compare our results with COVID-19 patients’ results from
different places around the world, this would clearly unleash the role of the different
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environmental factors contributed to the escalating burden of antibiotic resistance
among COVID-19 patients.
In the near future, we should see a new era of development of bioinformatics
tools and software based on different machine learning approaches to eliminate any
current limitations and also trying to put a clear workflow optimizing the mechanism of
BGC and AMR gene detection and expression of their corresponding secondary
metabolites and AMR genes, respectively.
A final word to all people around the world, please keep antibiotics for patients
with clear and documented signs of bacterial infection, the misuse of antibiotic will
accelerate the arrival of the post-antibiotic era. Dr. Nino the director of WHO, European
division said, “Everyone has a role to play as an antibiotic guardian, whether they are a
parent, a prescriber or a policy-maker.”
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